The Lung Flashcards

1
Q

respiratory system embryology

A

Outgrowth from the ventral wall of the foregut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lobar bronchi lined with what and do what

A

Columnar calibrated epithelium with abundant subepithelial glands that produce mucus, which impedes the entry of microbes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tell my about the lungs double arterial supply

A

Pulmonary arteries from the heart carry de oxygenated blood to the alveoli
Bronchial arteries from the aorta carry oxygenated blood to the parenchyma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lining of the respiratory tract

A

Pseudostratified ciliated columnar epithelium with goblet cells

Neuroendocrine cells are present that release several factors
-serotonin 5HT, calcitonin, gastrin releasing peptide (bombesin)

Mucus secreting goblet cells and submucosal glands are dispersed through the walls of the trachea and bronchi, but not the bronchioles and distal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Exception: what are the vocal cords lined by

A

Stratified squamous epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alveolar epithelium

A

Continuous layer of two cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alveolar epithelium type I

A

95%

Flattened and plate like

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rounded type II pneumocytes alveolar epithelium

A

Synthesize surfactant

Repair alveolar epithelium by giving rise to type I—stem cel like

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pulmonary hypoplasia

A

Defective lung development due to abnormalities that compress the lung or impede normal expansion in utero (diaphragmatic hernia or oligohydramnios)

Diminished weight, volume, and acinar number for body weight and gestational age

If severe, can be fatal in the early neonatal period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Foregut cysts

A

Due to abnormal detachment of primitive foregut

Most often in hilum or middle mediastinum

Bronchogenic (most common), esophageal, or enteric—depending ont he wall structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchogenic cysts

A

Most commmon and is rarely connected to the tracheobronchial tree

Lined with ciliated pseudostratified columnar epithelium with glands, cartilage and smooth muscle in the wall

Usually found incidentally of there is compression of nearby structures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pulmonary sequesteration lung tissue

A

Lacks any connection to the airway system

Has abnormal vascular supply arising from the aorta or its branches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Extra lobar sequesteration

A

Lack connection to the airway system and are external to the lung

Has own pleura

Generally come to attention as mass lesions in infants

Often associated with other congenital anomalies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intra lobar sequesteration

A

Occur within the lung parenchyma
Does not have its own pleura

Lack connection to the airway system

Occur in older children due to recurrent localized infection or bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neonatal RDS

A

Most common where a layer of hyaline proteinaceous material int he peripheral airspace’s of infants who have the condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other causes of neonatal respiratory distress syndrome

A

Excessive sedation of mom, fetal head delivery during birth, aspiration of blood or amniotic fluid, or intrauterine hypoxia fromthe umbilical cord around the neck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does neonatal respiratory distress present

A

Preterm with appropriate weight, may need assistance breathing during the first few minutes, then normal, then problems in 30 min, cyanosis in a few hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lungs RSD

A

Fine rales in lung fields

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CXR RSD

A

Uniform minute reticulogranular densities that look like ground glass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prognosis neonatal RSD

A

Infant will typically be able to survive if the therapy is able to keep them alive for the first few days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Who gets neonatal RSD

A

Males, maternal diabetes, delivery by C section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pathogensisof RDS

A

Immaturity of th lungs is the most important thing for RDS to develop

Happens to 60% of infants bone less than 28 weeks

Fundamental problem is a lack of surfactant and thus too much surface tension int he alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Surfactant composition

A

Defense proteins: SP-A and SP-D

Surfactant proteins : SP-B, SP-C and surfactant lipids
-can measure these in an amniocentesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Surfactant genes

A

SFTPB, SFTBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Surfactant defiency issue
Infants need the surfactant to properly inhale with less effort, but if they don’t have any then each progressive breath the lungs collapse a little more This problem of stiff atelectatic lungs is compounded by a soft thoracic wallet hat is pulled in as the diaphragm descends
26
Progressive atelectasis and reduced lung compliance->
Protein rich, fibrin rich exudation into the alveolar spaces with the formation of hyaline membranes - fibrin hyaline membranes are barriers to gas exchange->CO2 retention and hypoxemia - hypoxemia impairs further surfactant synthesis Hypoventilation !!!
27
What does hypoventilation from RSD lead to
Acidosis and pulmonary vasoconstriction (from the relative hypoxia) leading to pulmonary hypoperfusion causing tissue damage and plasma leak into the alveoli Ultimately there are necrotic cells and fibrin deposition with a hyaline membrane being laid down and exacerbating the problem in a viscous cycle
28
Surfactant synthesis
Produced by type II pneumocytes Modulated by cortisol (glucocorticoids most important*), prolactin, thyroxine, and TGFB
29
Conditions associated with what increase ___ release and lower the risk of developing RDS
Intrauterine stress and FGR Corticosteroid
30
Diabetic mom
Increased glucose in mother leads to increased insulin in fetuses. Increased insulin in fetus inhibits synthesis of surfactant by way of inhibiting the steroids leading to a greater risk of RDS - infants of diabetic mom have higher risk of developing RDS - treat with corticosteroid therapy
31
How treat infant of diabetic mother
Corticosteroid therapy
32
Labor and surfactant
Labor increases surfactant synthesis
33
C section before onset of labor
Increases risk of RDS C section is less stressful for baby and labor increases surfactant
34
Morphology RDS
Lungs are normal size, solid airless, and reddish purple in color Alveoli are poorly developed and collapsed—atelectasis Necrotic cells (including type II pneumocytes) can be seen early and later they are incorporated within eosinophilic hyaline membranes that are also composed of fibrin NEVER seen in stillborn Infants that survive more than 48 hours will have reparative changes int he lungs where the alveolar epithelium proliferated under the surface of the membrane and detach into the airspace where is digested by macrophages
35
Clinical features of RDS
Clinical course and prognosis depends on the maturity and birth weight of the infant and the promptness of institution of therapy (administration of surfactant: poractant Alfa, bear tang, calfactant) Best thing to do is delay labor long enough to reach maturity or induce maturation of the lungs
36
Best way to check on lung maturity
Sample the phospholipids in the amniotic fluid - phosphatidylcholine is important for surfactant - measure a lecithin: phosphatidylcholine ratio; want it to be greater than 2:1?
37
In uncomplicated cases of RDS when get recovery
3-4 days
38
Complications from high concentration of ventilator administered oxygen for prolonged periods for infants with RDS
Retrolental fibroplasia Bronchopulmonary dysplasia
39
Retrolental fibrosis(retinopathy of prematurity)
Phase I: hyperoxaluria; expression of VEGF is decreased and causing endothelial cell apoptosis Phase II:VEGF levels rebound after return to relatively hypoxic room air -induced retinal vessel proliferation (neovascularization) that is characteristic of the retina lesions
40
Bronchopulmonary dysplasia
Major abnormality: striking decrease in alveolar septation (manifested as large, simplified alveolar structures) and a dysmorphic capillary configuration caused by a potentially reversible impairment in the development of alveolar septation at the "saccular stage" Multiple factors: hyperoxemia, hyperventilation, prematurity, inflammatory cytokines (TNF, IL-1, IL-6, and IL-8), and vascular maldevelopment
41
Infants who recover from RDS are at an increased risk of
PDA, intraventricular hemorrhage, necrotizing enterocolitis
42
Atelectasis (collapse)
Incomplete expansion of the lungs (neonatal atelectasis) or collapse of previously inflated lung producing areas of relatively airless pulmonary parenchyma Can reduce oxygenation and predispose to infection Reversible (except in contraction)  
43
Resorption atelectasis=obstruction
Complete airway obstruction air is resorbed from the dependent alveoli which then collapse Mediastinum shifts towards the affected lung because lung volume is diminished most often caused by excessive secretions (mucus plug) or exudates within smaller bronchi as may occur in bronchial asthma, chronic bronchitis, bronchiectasis, or post-operative setting Can also be due to aspiration or tumor fragments
44
Compressive atelectasis=pleural effusion
occur whenever significant volumes of fluid accumulate within the pleural cavity Transudate (hydrothorax), exudate (pleural effusion), blood (hemothorax), air (pneumothorax), tumor Effusion from cardiac failure/neoplasm Blood from aneurysm rupture Mediastinum shifts away from the affected lung
45
Contraction atelectasis =fibrosis
focal or generalized pulmonary or pleural fibrosis prevent full expansion Mediastinum can shift toward the affected lung if it is ipsilateral, no change if it is bilateral Irreversible  
46
Pulmonary edema
leakage of excessive interstitial fluid in alveolar spaces due to: Increased hydrostatic pressure Increased capillary permeability Leads to heavy, wet lungs regardless of etiology Decreased oxygenation -- diffusion barrier is increased --> cyanosis, dyspnea, low O2 sat Predisposes patient to infection Therapy and outcome depend on the etiology  
47
Hemodynamic pulmonary edema
Engorged alveolar capillaries due to increased hydrostatic pressure, often a result of left-sided heart failure Fluid accumulation occurs in basal regions of lower lungs first (dependent edema) Granular, pink precipitates in the alveolar spaces Chronically leads to brown, firm lungs (brown induration) due to interstitial fibrosis and hemosiderin laden macrophages (pathognomonic "heart failure cells")
48
Edema caused by microvascular (alveolar injury
due to injury of the alveolar septa inflammatory exudate that leaks into the interstitial space and, in more severe cases, the alveoli in most forms of pneumonia, the edema remains localized and is overshadowed by the manifestations of infection If diffuse/severe can lead to Acute Respiratory Distress Syndrome (ARDS)
49
Acute lung injury and acute respiratory distress syndrome (diffuse alveolar damage)
Ok
50
Noncardiogenic pulmonary edema (acute lung injury ALI)
Abrupt onset of hypoxemia and bilateral pulmonary infiltrates in the absence of heart failure Increased pulmonary vascular permeability due to epithelial cell death ARDS is a manifestation of severe ALI/DAD ARDS and ALI are associated with inflammation-associated increases in pulmonary vascular permeability, edema, and epithelial cell death histologically, this is recognized as diffuse alveolar damage (DAD) due to localized or systemic insult Sepsis, diffuse pulmonary edema, gastric aspiration, and trauma account for more than 50% of the cases Worse prognosis in smokers and alcoholics pathogenesis is a "viscous cycle of increasing inflammation and pulmonary damage
51
ARDS is a manifestation of
Severe ALI/DAD
52
ALI/ARDS: endothelial activation
There is injury to pneumocyte injury that is recognized by resident macrophages ("dust cells") Can also be activated by systemic factors in times of sepsis Then there is increased endothelial permeability and adhesion molecules There are also increased production and secretion of procoagulant proteins and chemokines
53
ALI/ARDS: adhesion and extravasion of neutrophils
neutrophils come in and degranulate --> release inflammatory mediators including proteases, reactive oxygen species, and cytokines macrophage inhibitory factor (MIF) helps to sustain the pro-inflammatory response result: increased recruitment and adhesion of leukocytes --> more endothelial injury --> local thrombosis this cycle of inflammation and endothelial damage lies at the heart of ALI/ARDS
54
ALI/ARDS: accumulation if intraalveolar fluid and formation of hyaline membranes
The alveolar caps become leaky and allow the edema to come in Type II pneumocytes are damaged which results in surfactant-related issues (i.e. gas exchange becomes worse --> shortness of breath) The protein-rich fluid and dead epithelial cells then forms in hyaline membranes (characteristic of ALI/ARDS
55
ALI?ARDS: resolution of injury
Impeded due to epithelial necrosis and inflammatory damage that impairs edema resorption Eventually, if the inflammation lessens then the macrophages can clean everything up and heal the damaged areas with fibrogenic factors (i.e. TGF-β and PDGF) There is then fibrosis of the alveolar walls and bronchiolar stem cell replacement of pneumocytes Type II Pneumocytes replace the pneumocytes, act as stem cells
56
ALI?ARDS: acute morphology
Lungs are diffusely firm, red, boggy and heavy (hyperemic and congested?) Congestion with interstitial and intraalveolar edema, inflammation, fibrin deposition, and diffuse alveolar damage Lined with hyaline membranes (composed of necrotic epithelial debris and exuded proteins) morphologically similar to those seen in hyaline membrane diseases of neonates alveolar hyaline membranes consist of fibrin-rich edema fluid mixed with the cytoplasmic and lipid remnants of necrotic epithelial cells (protein-rich exudate) Characteristic histologic picture of ARDS is that of hyaline membranes lining alveolar walls. Edema, scattered neutrophils and macrophages, and epithelial necrosis are also present
57
ALI/ARDS: organizing stage morphology
Type II pneumocyte proliferation Granulation tissue forms in the alveolar walls as a response to the hyaline membranes most cases: granulation tissue resolves and leaves only minimal functional impairment can progress to interstitial fibrosis with severe scarring Superimposed bronchopneumonia can be fatal
58
ALI/ARDS: clinical
LI/ARDS: Clinical ALI or ARDS patients are usually already admitted for one of the predisposing conditions (e.g. sepsis, severe head trauma) Dyspnea and tachypnea are characteristic --> cyanosis, hypoxemia, respiratory failure, and the appearance of diffuse bilateral infiltrates follow hypoxemia may be refractory to oxygen therapy due to ventilation/perfusion mismatching Respiratory acidosis can develop (can't blow off CO2 as effectively --> buildup of CO2 --> acidosis) Stiff lungs from the lack of surfactant can develop early in the course Functional abnormalities are not evenly distributed Poorly aerated regions are still perfused = V/Q mismatch & hypoxemia Ventilation is occurring, but there in not as much perfusion as expected
59
Mortality ALI/ARDS
40% secondary to sepsis of multi organ failrue
60
ALI/ARDS:treatment
Mechanical ventilation while treating the underlying cause no proven specific treatments -- treatment of the underlying cause has improved Most patients will recover, but many of them can still have physical and cognitive impairment most deaths are attributable to sepsis or multiorgan failure and, in some cases, direct lung injury In minority of cases, exudate and diffuse tissue destruction --> scarring, interstitial fibrosis, and chronic pulmonary disease  
61
Acute interstitial pneumonia (idiopathic (ALI/DAD)
Widespread ALI of unknown etiology with a rapidly progressive clinical course Present with acute respiratory failure within 3 weeks of URI Imaging/pathology identical to organizing ALI Average age: 59; No gender preference 33-74% mortality, typically in first 12 months Morphology is the same as the organizing stage of ALI Progresses rapidly with most deaths occurring in 1-2 months Survivors are prone to recurrence and chronic interstitial disease
62
Obstructive and restrictivelung diseases
Increased resistance to airflow due to partial or complete obstruction at any level Decreased maximal flow rates during forced expiration FEV1 / FVC < 0.8
63
Restrictive lung disease
Decreased expansion of the lung parenchyma and decreased total lung capacity Chest wall disorders (e.g. severe obesity, pleural diseases, kyphoscoliosis, and poliomyelitis) Chronic interstitial and infiltrative disease (e.g. pneumoconioses and interstitial fibrosis) Proportionate Decreased in lung capacity and FEV1 --> FEV1 / FVC is normal
64
Chest wall disorders
Severe obesity, pleural diseases, kyphoscoliosis, and poliomyelitis
65
Chronic interstitial and infiltrating disease
Pneumoconiosis and infiltrative disease
66
Obstructive lung disease FEV1/FVC
67
Restrictive lung disease FEV1/FVC
Normal
68
Obstructive lung disease examples
COPD(emphysema, chronic bronchitis) Asthma Bronchiectasis
69
Chronic bronchitis
Anatomical site-bronchus Major pathological changes-mucous gland hyperplasia, hypersecretion Etiology:tobacco smoke, air pollutants Signs and symptoms :fought sputum production
70
Bronchiectasis
An atomic site: bronchi Major pathology changes: airway dilation and scarring Etiology: persistent or severe necrotizing infections Signs and symptoms: cough, pursuant sputum, fever
71
Asthma
Anatomic site: bronchus Major pathological changes: smooth msucle hyperplasia, excess mucus, inflammation Etiology: immunologic or unknown; drug induced Signs and symptoms: episodic wheezing, cough, dyspnea
72
Emphysema
Anatomic site: acinus Major pathological changes: airspace enlargement, wall destruction->blebs Etiology: tobacco smoke: highly Signs and symptoms: dyspnea
73
Small airway disease(variant of chronic bronchiolitis)
Can be seen with any form of obstructive disease or as an isolated finding: contributes to obstruction both in emphysema and chronic bronchitis
74
Reversible bronchitis
Asthma == reversible bronchospasm chronic bronchitis and emphysema == irreversible bronchospasm *Generally
75
COPD
C ommonly includes emphysema and chronic bronchitis Increased risk: Cigarette smoking, female, African American, environmental/occupational pollutants, airway hyperresponsiveness, genetic polymorphisms
76
Emphysema
I rreversible enlargement of airspaces distal to the terminal bronchioles Alveolar wall destruction without obvious fibrosis, except in the small airways Classified by anatomic distribution within the lobule -- centriacinar*, panacinar*, paraseptal, and irregular lobule == cluster of acini (terminal respiratory units) *only the first two cause clinically significant airflow obstruction
77
Centriacinar (centrilobular emphysema)
Destruction and enlargement of the central or proximal parts of the acini, formed by respiratory bronchioles, sparing distal alveoli Emphysematous and normal airspaces exist within the same acinus and lobule Predominantly upper lobes and apices When severe, the distal acini may be involved (difficult to distinguish against panacinar emphysema) *Heavy smokers* and often associated with chronic bronchitis (COPD) Most common form of emphysema 95% of cases
78
Where is centriacinar emphysema, who gets it
Upper lobes and spices Smokers
79
Most common form of emphysema
Centriacinar emphysema
80
Panacinar (panlobular) emphysema
Uniform destruction and enlargement of the entire acini from the level of the respiratory bronchiole to the terminal blind alveoli Common in the lower zones and anterior margins of the lung Most severe at the lung bases Associated with α1-antitrypsin deficiency  
81
Distal acinar emphysema
Proximal acinus is normal; distal acinus is predominantly affected Prominent near the pleura, along septa and lobules and occurs adjacent to fibrosis/scarring/atelectasis More severe in the upper half of the lungs Multiple, continuous, enlarged airspaces that may sometimes form cyst-like structures -- "blebs" Commonly the underlying lesion in spontaneous pneumothorax in the young
82
Airspace enlargement with fibrosis (irregular emphysema)
Acinus is irregularly involved Invariable associated with scaring Clinically insignificant
83
Pathogenesis of emphysema
parenchymal destruction == emphysema | airway disease == bronchiolitis and chronic bronchitis
84
Emphysema pathogenesis L inflammatory mediators
Increased levels in the affected areas -- leukotriene B4, IL-8, TBF, and others Released by resident epithelial cells and macrophages Attract inflammatory cells from circulation (chemotaxis) Amplify inflammation (cytokines) Induce structural changes (GFs)
85
Emphysema pathogenesis : protease antiprotease balance
connective tissue is broken down by enzymes released from the inflammatory and epithelial cells Loss of elastic tissue = respiratory bronchiole collapse during expiration causing functional obstruction Deficiency of antiproteases (may be genetic) is common in patients with emphysema α1-antitrypsin == anti-protease; deficiency upsets the balance --> panlobular emphysema trypsin is a protease; anti-trypsin is an anti-protease -- don't get fucked up on words
86
Emphysema pathogenesis: oxidative stress
Oxidants are produced by tobacco smoke, from alveolar damage, and from inflammatory cells NFR2 inactivation: significantly increased sensitivity to tobacco smoke NFR2 is a sensor for oxidants in alveolar epithelial cells Activated by intracellular oxidants to upregulate genes that protect from oxidant damage NFR2 == transcription factor that upregulates expression of multiple genes that protect cells from oxidant damage
87
Emphysema pathogenesis : infection
Thought to exacerbate the associated inflammation and chronic bronchitis
88
A1 antitrypsin (anti-protease) and emphysema
Found in 1% of all patients anti-protease: protects against proteases, especially elastase (released by neutrophils) Much more likely to cause emphysema, especially if the patient smokes Encoded on the Pi locus of chromosome 14 patients with the Z allele have decreased serum levels and 80% of homozygotes (piZZ) will develop symptomatic panacinar emphysema which is even more accelerated and severe if the patient smokes
89
Nicotinic acetylcholine receptor and emphysema
Some genetic variants of the receptor can lead to an increased risk for the disease Makes smoking more addictive and thus increases the risk of the disease smoke more and smoking is even worse for you
90
Physiology emphysema
small airways are normally held open by the elastic recoil of the lung parenchyma loss of elastic tissue in the walls of alveoli that surround respiratory bronchioles reduces radial traction and thus causes the respiratory bronchioles to collapse during expiration --> functional airflow obstruction
91
Smoking and airway changes, found even in young smokers
goblet cell hyperplasia and mucus plugging of the lumen inflammatory infiltrates in bronchial walls -- neutrophils, macrophages, B-cells, and T-cells bronchiolar wall thickening due to fibrosis and smooth muscle hypertrophy --> increased airway obstruction
92
Emphysema morphology
Diffuse disease: voluminous lungs that overlap the heart Alveolar wall rupture can produce huge airspaces (blebs and bullae) that are more commonly found in the upper 2/3 of the lungs that compresses the bronchioles and vasculature Alveolar spaces are enlarged and separated by thin septa with only focal centriacinar fibrosis The Pores of Kohn are large and look to be clubbed shape and protrude blindly into the alveolar spaces Septal capillaries are compressed and bloodless
93
CLINCIALLY emphysema
Dyspnea, wheezing, cough begin to occur when 1/3 of pulmonary parenchyma is lost Cough and expectorant are very variable and depend on the level of the associated bronchitis Severe weight loss (confused with occult cancer) Barrel chested, dyspneic, hunched over, breathes through pursed lips impaired expiratory airflow (best measured through spirometry) is the key to diagnosis 'Pink puffers' well oxygenated at rest due to overventilation chronic bronchitis == blue bloaters emphysema == pink puffers
94
Prognosis emphysema
Development of cor pulmonale is a poor prognostic factor Death due to: Coronary Artery Disease Respiratory Failure Right Heart Failure Massive collapse of lungs 2° to pneumothorax
95
Treat emphysema
Smoking cessation O2 therapy Long acting bronchodilators (tiotropiums and ipratropium) with inhaled corticosteroids physical therapy Bullectomy Lung volume reduction surgery (select patients) Lung transplant (select patients) α1-antitrypsin replacement therapy is currently being evaluated
96
Other forms of emphysema
Associated with lung overinflation or focal emphysematous change
97
Compensatory hyperinflation emphysema
Dilation of alveoli in response to loss of lung parenchyma elsewhere hyper-expansion of residual lung parenchyma following surgical removal of diseased lung or lobe
98
Obstructive overinflation emphysema
Foreign body (tumor, foreign object) creates a subtotal obstruction -- the lung expands because air is trapped Congenital Lobar Overinflation in infants due to hypoplasia of bronchial cartilage sometimes associated with other congenital cardiac and lung abnormalities Overinflation in Obstructive Lesions Ball-valve phenomenon which admits air on inspiration but traps it on expiration Collaterals introduce air behind the obstruction pores of Kohn canals of Lambert (bronchioalveolar connections) Can be life-threatening as the affected lung can compress the remaining lung
99
Bulbous emphysema
Large sub-pleural bullae or blebs that can occur with any type of emphysema Bullae: spaces of air that are greater than 1cm Occurs near the apex Often near old tuberculous scarring Rupture can cause pneumothorax
100
Interstitial emphysema
Entry of air into connective tissue of the lung, mediastinum, or subcutaneous tissue In most cases is due to alveolar tears in pulmonary emphysema allowing air to enter the stroma of the lungs, but can also be due to chest wound or fractured rib rapid increases in pressure within the alveolar sacs (e.g. coughing with bronchiolar obstruction) premature infants on positive pressure ventilation are most at risk Artificially ventilated adults
101
Chronic bronchitis
Persistent cough with sputum production for at least three months in at least two consecutive years in the absence of other identifiable causes Can accelerate decline in lung function, cause cor pulmonale and HF or atypical metaplasia of respiratory epithelium (fertile grounds for cancerous transformation) Common in smokers and smog-laden cities COPD spectrum == emphysema to chronic bronchitis most patients have features of both associate Reid Index with Chronic Bronchitis
102
Pathogenesis chronic bronchitis
Predominantly due to chronic irritation from inhaled substances/irritants such as tobacco smoke (90% of patients also smoke) and also dust from grain, silica, or cotton earliest feature == hypersecretion of mucus in the large airways associated with hypertrophy of the submucosal glands in the trachea and bronchi With time there is increased numbers of goblet cells in the smaller airways too Chronic inflammation leads to fibrosis and obstruction of the small airways Exacerbated by 2° infections Smoking inhibits cilia to prevent the clearing of mucous and thus increased risk of infection
103
Morphology chronic bronchitis
Hyperemia (excessive blood vessels) Edema of lung mucous membranes mild chronic inflammation of the airways (predominantly lymphocytes) and enlargement of the mucus-secreting glands of the trachea and bronchi -- characteristic features of chronic bronchitis Mucinous secretions filling airways Mucous gland hyperplasia hyperplasia == increase in size Reid Index == ratio of the thickness of the mucous gland layer to the thickness of the wall between the epithelium and the cartilage Normally is .4 or 40%; increased in chronic bronchitis in proportion to the severity and duration associate Reid Index with chronic bronchitis -- just the glandular component don't use the Reid Index for asthma Bronchiolar inflammation, fibrosis, and gland hyperplasia leads to airway obstruction Bronchial epithelium may exhibit squamous metaplasia + dysplasia There is marked narrowing of bronchioles caused by mucus plugging, inflammation, and fibrosis Severe: bronchiolitis obliterans (fibrosis causes obliteration of the lumen in severe cases
104
Clinical chronic bronchitis
y Persistent cough productive of sparse sputum for at least three consecutive months in at least two consecutive years eventually, dyspnea on exertion develops hypercapnia (retain CO2), hypoxemia and mild cyanosis over time -- "blue bloaters" chronic bronchitis == blue bloaters emphysema == pink puffers Can lead to cor pulmonale and heart failure Death is possible from further impairment of respiratory function due to superimposed acute infections
105
Asthma
disorder of the conducting airways episodic reversible bronchospasm due to smooth muscle hyperreactivity, inflammation of the bronchial walls, and increased mucus production Leads to cough, wheeze, chest tightness, and breathlessness, especially at night and in the morning
106
Classes of asthma
Atopic (most common0 | Nonatopic
107
Atopic asthma
Classic IgE-mediated (Type I) hypersensitivity reaction triggered by environmental allergens (e.g. pollen, food) that is synergistically triggered by other proinflammatory things in the environment and viral infections
108
Early onset allergic asthma
Associated with TH2 helper T cell mediated inflammation and responds well to treatment with corticosteroids
109
Genetic atopic asthma
Family history common
110
Skin test atopic asthma
Immediate wheal and far reaction to the antigen they are sensitized to
111
Serum test atopic asthma
Levels of allergen sensitization shown by RAST which can detect the presence of IgE antibodies that are specific for individual allergens
112
Nonatopic asthma
No evidence of allergen sensitization Negative skin test Genetic involvement less common viral respiratory infections are common triggers, as well as inhaled air pollutants (smoking, sulfur dioxide, ozone, and nitrogen dioxide == smog) that can cause chronic airway inflammation and hyperreactivity ozone has no pathologic effects; it is only an irritant Can even be caused by cold or exercise
113
Drug induced asthma (triad asthma)
Aspirin sensitive asthma == uncommon; occurs in individuals with recurrent rhinitis and nasal polyps exquisitely sensitive to small doses of aspirin and other NSAIDs asthmatic attacks + urticaria (hives) Inhibition of COX pathway --> decreased PGE2 --> increase in pro-inflammatory leukotrienes NSAIDs More likely to occur in individuals with recurrent rhinitis and nasal polyps
114
Occupational asthma
Minute quantities of chemicals induces signs and symptoms after repeated exposure Varying underlying mechanisms
115
Asthmatic bronchitis
Seen in smokers
116
Early phase atopic asthma
TH2 hyperreactivity leads to: IL-4: production of IgE -- "5Always and 4Ever" IL-5: activates eosinophils IL-13: stimulates bronchial submucosal glands to secrete mucous and B-cells to make more IgE Antigen binding to IgE coated mast cells causes primary and secondary mediator release that cause: T-lymphocytes and epithelial cells secrete chemokines that recruit more T-lymphocytes and eosinophils and exacerbate the problem
117
Early phase atopic asthma
Bronchoconstriction triggered by direct stimulation of subepithelial vagal (parasympathetic) receptors through both central and local reflexes increased mucus production variable degrees of vasodilation increased vascular permeability
118
Late phase atopic asthma (hours
dominated by the recruitment of leukocytes, notably eosinophils, neutrophils, and more T-cells Persistent bronchospasm and edema Leukocytic infiltration Epithelial damage and loss Repeated bouts lead to airway remodeling -- asthma == airway remodeling Hypertrophy and hyperplasia of bronchial smooth muscle and mucus glands Increased vascularity Increased deposition of subepithelial collagen TH2 is the dominant cell type TH17 T-cells are also present and they are the ones that recruit neutrophils down regulation of IL-17 == cold abscesses
119
Mediators whose role in asthmatic bronchospasm is clearly supported by. Pharmacological intervention
Leukotrienes C4, D4, E4 Acetylcholine
120
Leukotrients C4, D4, E4
Prolonged bronchoconstriction, vascular permeability, and mucus secretion
121
Acetylcholine
Stimulation of muscarinic receptors causing airway smooth muscle constriction
122
Mediators found in asthmatic bronchospasm, but not significant targets of pharmaceutical intervention
``` Histamine PGD2 PAF Cytokines and chemokines ^might prove important in certain types of chronic or non allergic asthma ```
123
Histamine:
Bronchoconstrictor
124
PGD2
Bronchoconstriction and vasodilation
125
Asthma genetics
Patients with atopic asthma are more likely to have other allergic disorders like allergic rhinitis and eczema Implicated genes can affect 1° or 2° immune responses, tissue remodeling or the patients response to therapy
126
Gene cluster involving IL3, IL4 IL5 IL9 IL13 and IL4R, on chromosome 5q
Polymorphism in the IL13 gene have the strongest and most consistent association with asthma
127
Genetics asthma
``` IL4R HLA class II ``` ADAM33 leads to bronchial smooth muscle and fibroblast proliferation B2-adrenergic receptor (airway reactivity) YKL-40: increased levels of the China tase-like glycoproteins is directly correlated with disease severity , airway remodeling, and decreased pulmonary function
128
Environmental factors
City Living -- there are many airborne pollutants that may initiate the TH2 response; city life limits the exposure of very young children to certain antigens infections themselves are not a cause of asthma young children with aeroallergen sensitization who develop lower respiratory tract viral infections (rhinovirus type C, respiratory syncytial virus) have 10-30x increased risk of developing persistent and/or severe asthma viral and bacterial infections are associated with acute exacerbations of the disease airway remodeling = structural changes in the bronchial wall brought on as a result of repeated bouts of allergen exposure and immune reactions; irreversible component hypertrophy and hyperplasia of bronchial smooth muscle epithelial injury increased airway vascularity increased subepithelial mucus gland hypertrophy deposition of subepithelial collagen
129
Asthma morphology
The following is especially found in patients with status asthmaticus Overinflated lungs with patchy atelectasis Mucus plugging of airways that also contains shed epithelium Whorled mucus plugs (Curschmann spirals) Microscopic lung edema, with eosinophils and Charcot-Leyden crystals (eosinophilic protein galectin-10) Airway remodeling == irreversible component; this is seen in asthma Thickening of airway wall Subbasement membrane fibrosis (deposited I and III collagen) Increased vascularity Bronchial wall smooth muscle and mucosal gland hypertrophy
130
Clinical course asthma
``` Attacks can be hours long Chest tightness Prolonged expiration Peripheral blood eosinophilia Wheezing Dyspnea Cough **atopic dermatitis**: rash on flexural surfaces asthma == eosinophils, IL-5, Curschmann spirals, Charcot-Leyden crystals ```
131
Status asthmaticus
Severe form of asthma where the paroxysm persists for days and weeks Airflow obstruction may be so severe it causes cyanosis or death
132
Asthma and puberty
About half of the cases will remit, but lots of cases will return in adulthood
133
Bronchiectasis
Destruction of smooth muscle and elastic tissue by chronic necrotizing infections that leads to permanent dilation of bronchi and bronchioles becoming less common due to infection control
134
Etiology bronchiectasis
Congenital or hereditary conditions like cystic fibrosis and primary ciliary dyskinesia Infection(s), including *necrotizing pneumonia caused by bacteria, viruses, and fungi Bronchial obstruction, due to tumor, foreign body, or mucus impaction bronchiectasis is localized to the obstructed lung segment Chronic inflammatory states: RA, lupus, IBD, COPD, post-lung/bone marrow transplant 25-50% of cases are idiopathic
135
Pathogenesis bronchiectasis
Obstruction and infection are both necessary but can occur in either order Bronchial obstruction impairs normal clearing mechanisms secretions pool distal to the obstruction and can lead to secondary infection and inflammation Severe infections can lead to inflammation accompanied by necrosis, fibrosis, and eventually airway dilation The smaller airways can become obliterated: bronchiolitis obliterans
136
Cystic fibrosis
Abnormal function or loss of an epithelial chloride channel (CFTR) on chromosome 7
137
CFTR transports Cl
Sweat glands: from the surface into the cell | Other epithelia: from the cell to the lumen
138
CFTR ENaC
CFTR inhibits ENaC which is found on epithelial cell apical surfaces (except on sweat glands) and thus in CF it is overactive taking up water and Na+ ions from the mucus in the lungs
139
What does dehydration of the airway mucus lead to in CF
T he dehydration of the airway mucus leads to decreased ciliary activity and an inability for the body to clear mucous and microbes --> airway obstruction, predispose to (necrotizing) infection --> bronchiectasis primary defect in ion transport --> defective mucociliary action and airway obstruction by thick secretions chronic bacterial infections are common --> widespread damage to airway walls
140
Bacterial pathogenesis CF
Staphylococcus aureus, haemophilus influenzae, and burkholderia capacia
141
Pseudomonas aeruginosa CF
Can produce a mucosa capsule (alginate)->protective biofilm
142
Primary ciliary dyskinesia
Autosomal recessive Defect in ciliary motor proteins (dynein) --> retention of secretions --> recurrent infection --> bronchiectasis Half of patients also have Kartagener Syndrome: situs inversus or partial lateralizing abnormality, bronchiectasis, and sinusitis Males usually infertile due to sperm dysmotility
143
Allergic bronchopulmonary asperigillosis
Occurs in patients with asthma and cystic fibrosis who develop periods of exacerbation and remission which can lead to proximal bronchiectasis and fibrotic lung disease Hypersensitivity to the fungus aspergillus fumigatus Activation of TH2 helper T cells that recruit eosinophils and other leukocytes Elevated IgE serum antibodies to the fungus Characterized by formation of mucous plugs and intense airway inflammation with eosinophils
144
Bronchiectasis morphology
Most severe changes in the peripheral lower lobes Affects the more distal bronchi and bronchioles, especially the vertical ones Can affect just a single lung segment if caused by tumors or aspiration of a foreign body Airways may be dilated up to 4x the normal size Appear cystic and filled with mucopurulent secretions In severe cases there can be inflammatory exudation within the walls of the airways that is associated with desquamation of the lining epithelium and lots of ulceration For the rest of the tissue there may be pseudo stratification of the columnar cells or squamous metaplasia Sometimes the necrosis can lead to abscesses If chronic, there can be severe fibrosis and obliteration of the lumens
145
Bronchiectasis common pathogens
Staphylococcus (clusters), streptococcus (chains), enterics (gram negatives), anaerobic and microaerophilic pathogens (especially in pediatric populations), Haemophilus influenzae (vaccine), and pseudomonas aeruginosa
146
Bronchiectasis clincial course
signs and symptoms are often episodic and precipitated by URI Persistent, severe cough May be associated with morning or positional changes draining collected pus/secretions into the bronchi Fever, orthopnea, dyspnea, and cyanosis Abundant purulent sputum that is foul smelling and sometimes bloody
147
Complications bronchiectasis
Cor pulmonale Brain abscess Amyloidosis
148
Restrictive lung disorders
Chronic interstitial and infiltrative diseases - pneumoconiosis - interstitial fibrosis of unknown etiology Chest wall disorders -neuromuscular diseases (poliomyelitis, severe obesity, pleural diseases, kyphoscoliosis
149
Chronic interstitial pulmonary disease
signs and symptoms are often episodic and precipitated by URI Persistent, severe cough May be associated with morning or positional changes draining collected pus/secretions into the bronchi Fever, orthopnea, dyspnea, and cyanosis Abundant purulent sputum that is foul smelling and sometimes bloody
150
What happens in chronic interstitial pulmonary disease
L ong term development of cor pulmonale and 2° pulmonary HTN May be difficult to distinguish in late stages because all result in scarring and gross destruction of the lung End-Stage, or Honeycomb Lung CXR: bilateral lesions that take the form of small nodules, irregular lines, or ground glass shadows that all indicate interstitial fibrosis
151
Fibrosing diseases
Ok
152
Idiopathic pulmonary fibrosis -MUC5B
Clinicopathologic syndrome of unknown cause with progressive interstitial pulmonary fibrosis and respiratory failure Appears to occur in patients who are genetically susceptible to aberrant repair of recurrent alveolar epithelial cell injuries due to environmental exposures Profibrotic response Histologically, usual interstitial pneumonia (UIP) must be distinguished from other causes UIP == nonspecific pattern of fibrosis shared with connective tissue diseases, chronic hypersensitivity pneumonia, and asbestosis prototypic of restrictive lung disease
153
Risk factors for IPF
Environmental factors: Cigarette smoking, viruses, persistent GERD, metal fumes, wood dust, farming, hairdressers, and stone-polishing Genetic factors: MUC5B: Increased mucin secretion that increases susceptibility to downstream fibrosis this accounts for 1/3 of cases problems in creating surfactant --> unfolded protein response --> harms type II pneumocytes Telomerase: loss-of-function (i.e. autosomal recessive) mutations in TERT and TERC Age > 50 (this is an older person disease
154
Morphology IPF
histological pattern of fibrosis is referred to as usual interstitial pneumonia (UIP) this can usually be found on its characteristic appearance in CT scans Lower lobe predominance Patchy interstitial fibrosis (frim rubbery white areas) in sub-pleural and interlobular septal distribution Heterogenous lesions of different ages Earliest lesions contain lots of fibroblastic proliferation (fibroblastic foci) With time areas become more collagenous and less cellular Dense fibrosis and cystic spaces lined with hyperplastic type II pneumocytes or bronchiolar epithelium (end-stage lung, or honeycomb lung) May see signs of pulmonary artery hypertensive changes and diffuse alveolar damage (DAD == ARDS
155
Clinical IPF
55-75 years old at presentation with variable deterioration Gradually progressive DOE and dry cough Late: hypoxemia, cyanosis and clubbing despite anti-inflammatories and anti-proliferatives Median survival: 3 years after diagnosis Lung transplant is only definitive therapy
156
Only definitive treatment IPF
Lung transplant
157
Non specific interstitial pneumonia
Diffusely fibrosing disease of unknown etiology | lung biopsies lack the diagnostic features of any of the other well-characterized interstitial diseases
158
Morphology nonspecific interstitial pneumonia
Cellular pattern Mild/moderate chronic interstitial inflammation with lymphocytes and a few plasma cells Uniform or patchy distribution Fibrosing pattern Diffuse or patchy interstitial fibrotic lesions of the same stage (vs other UIP) fibroblastic foci, honeycombing, hyaline membranes and granulomas are absent
159
Clinical nonspecific interstitial pneumonia
patients have chronic dyspnea and cough for several months patients have a much better prognosis vs other interstitial pneumonias Nonsmoking females in 6th decade CT: bilateral, symmetric, predominantly lower lobe reticular opacities Cellular pattern patients tend to be younger than those with fibrosing and have a better prognosis
160
Crypto genie organizing pneumonia
formerly known as: (bronchiolitis obliterans organizing pneumonia (BOOP) Unknown etiology Cough, dyspnea Patchy subpleural or peribronchial consolidation on CXR *Masson Bodies: polypoid plugs of loose organizing connective tissue within alveolar ducts, alveoli, and often bronchioles Lesions are all of the same age No interstitial fibrosis or honeycombing, the lung architecture is normal patients may recover spontaneously, but most require six months of steroids Identical morphologic changes with infections/inflammatory lung injury organizing pneumonia with intra-alveolar fibrosis is most often seen as a response to infections or inflammatory injury of the lungs
161
Rheumatoid arthritis on the lung (caplan syndrome=RA and pneumonicosis)
30-40% of patients have pulmonary involvement in one of five ways Chronic pleuritis (+/- effusion) Diffuse interstitial pneumonitis and fibrosis Intrapulmonary rheumatoid nodules Follicular bronchiolitis Pulmonary HTN
162
Systemic sclerosis (scleroderma) on the lung
Diffuse interstitial fibrosis (nonspecific interstitial pattern more common than usual interstitial pattern) and pleural involvement occurs in this systemic autoimmune disease anti-DNA topoisomerase antibodies
163
Systemic lupus erythematous
Patchy, transient parenchymal infiltrates or occasionally severe lupus pneumonitis, as well as pleurisy and pleural effusions may occur anti-dsDNA, anti-Smith antibodies
164
Chronic interstitial lung disease
diffuse interstitial fibrosis of the lung --> restrictive lung diseases decreased lung compliance and decreased forced vital capacity, proportionally --> Normal FEV:FVC ratio  
165
Pneumoconiosis=fibrosing patterna
Definition Non-neoplastic lung reaction to inhalation of mineral dusts, organic and inorganic particulates, and chemical fumes/vapors encountered in the workplace result from well-defined occupational exposure to specific airborne agents as well as ambient air pollution, especially in urban environments (carbon dust from internal combustion engines) Genetic predisposition is likely because only a small percentage of exposed people develop occupational respiratory disease
166
Pathogenesis pneumoconiosis
depends on: amount of dust retained in the airway and lung (concentration, exposure) cigarette smoking impairs mucociliary clearance and significantly increases the accumulation of dust in the lungs + adds more shit tobacco smoke worsens the effects of all inhaled mineral dusts, especially asbestos Size, shape, particle buoyancy 1-5μm reach terminal alveoli and settle in lining (small particles are worse than large particles) Physiochemical reactivity (toxicity) and particle solubility small and highly soluble: rapid onset lung damage and acute lung injury large and less soluble: more likely to resist dissolution, persist for years, and evoke fibrosing collagenous pneumoconioses (e.g. silicosis) possible additional effects of other irritants (e.g. concomitant tobacco smoking) The particles may also be taken up by the epithelial cells or cross through and interact directly with macrophages and fibroblasts Particles may enter the lymphatics to initiate immune response or cause auto-immune
167
Coal workers pneumoconiosis
Spectrum of disease due to inhalation of coal particles and other forms of carbon dust Asymptomatic anthracosis simple coal workers pneumoconiosis: little to no pulmonary dysfunction complicated coal workers' pneumoconiosis aka progressive massive fibrosis (PMF) lung function is compromised Can develop emphysema and chronic bronchitis independent of smoking Presence of silica in the coal dust leads to worse and progressive disease favors progressive disease
168
Morphology coal workers pneumoconiosis
Anthracosis macrophage take up inhaled carbon dust and accumulate in interstitial tissue Black pigmented lesions formed by coal laden macrophages accumulate in the connective tissue along the pleural lymphatics or in organized lymphoid tissue along the bronchi or in the lung hilum Simple Coal Workers Pneumoconiosis 1-2mm coal macules with carbon-laden macrophages or slightly larger coal nodules that also contain a delineated network of collagen fibers concentrated in the upper lobes and upper zones of the lower lobes primarily adjacent to respiratory bronchioles (site of initial dust accumulation) With time there can be dilation of adjacent alveoli that gives rise to centrilobular emphysema Complicated Coal Workers Pneumoconiosis (CCWP) also known as Progressive Massive Fibrosis occurs on a background of simple disease; requires years to develop multiple, intensely blackened scars 1 cm or larger consisting of dense collagen and pigment center of the lesion is often necrotic, most likely due to local ischemia
169
Clinical coal workers pneumoconiosis
Generally benign, as mild forms have little effect on lung function CCWP may develop causing increased pulmonary dysfunction Pulmonary HTN Cor pulmonale CCWP can continue to worsen, even if exposure is eliminated Does not raise susceptibility of tuberculosis or cancer (in the absence of smoking) domestic indoor use of "smoky coal" (bituminous) for cooking and heating is associated with an increased risk of lung cancer death for both women and men
170
Silicosis
Definition Common lung disease due to inhalation of pro-inflammatory crystalline silicone dioxide slowly progressing, nodular, fibrosing pneumoconiosis that takes decades Increased risk in African Americans acute silicosis: characterized by the accumulation of abundant lipoproteinaceous material within alveoli etiology == heavy exposure over months to a few years Most prevalent chronic occupational disease in the world
171
Silicosis pathogenesis
crystalline forms of silica (quartz, cristobalite, and tridymite) are much more fibrogenic than amorphous phagocytosed silica crystals activate the inflammasome --> oxidants, cytokines (IL-1 and IL-18), and GFs --> fibroblast proliferation and collagen deposition Slowly growing collagenous scars -- takes decades to develop Coalesce: progressive massive fibrosis
172
Morphology silicosis
Nodules are pale or black from coal dust in the beginning Become larger, more diffuse with progression forming large areas of massive fibrosis (scars) that contains a central area of whorled collagen surrounded by dust laden macrophages histologic hallmark lesion characterized by a central area of whorled collagen fibers with a more peripheral zone of dust-laden macrophages Some may have central softening and cavitation from superimposed tuberculosis or ischemia Initial collagenous nodules in upper lung or hilar lymph nodes Thin sheets of calcification can happen around the lymph nodes (called egg shell calcification on CXR) calcium surrounding a zone lacking calcification silicosis == egg shell calcifications Polarized light: (weakly) birefringent silica particles
173
Silicosis clinical
CXR with fine nodularity in upper lungs pulmonary function tests are either normal or moderately affected early in the course SOB develops later in course with progressive massive fibrosis (most patients do not develop SOB) Continues to worsen even if exposure is eliminated Increased susceptibility to tuberculosis Onset is variable but usually slow and insidious (10-30 years after exposure), but can rarely be rapid with intense exposure 2x increased risk for lung cancer
174
Asbestos
Family of proinflammatory crystalline hydrated silicates associated with pulmonary fibrosis, carcinoma, mesothelioma and other cancers Think of shipyard workers, construction, demolition (ceiling insulation
175
Asbestos related illness
Localized fibrous plaques or diffuse pleural fibrosis Pleural effusions (recurrent) Parenchymal interstitial fibrosis (asbestosis) Lung carcinoma Mesothelioma: malignant tumor derived from the lining cells of pleural surfaces Laryngeal, ovarian, extrapulmonary neoplasms Increased risk of autoimmune or cardiovascular disease
176
Forms of asbestos
Amphiboles Serpentine
177
Amphiboles asbestos
More pathogenic form due to their aerodynamic properties and solubility Once trapped, gradually leach due to solubility
178
Serpentine asbestos
Less pathogenic form due to flexible curled shape More likely to become impacted in the upper respiratory passages and subsequently removed by mucocillary elevator
179
Less pathogenic serpentine(chrysotile) accounts for what percent of asbestos used in injury
90%
180
Pathogenesis asbestos
both amphiboles and serpentines are fibrogenic, and increasing doses are associated with a higher incidence of asbestos-related disease (follows a dose-response curve) asbestos can also act as a tumor initiator and promoter -- unlike other inorganic dusts asbestos fibers activate the inflammasome and stimulate the release of proinflammatory factors and fibrogenic mediators Alveolar macrophages ingest the inhaled fibers and produce mediators when activated Fibers act as tumor initiators and promoters Oncogenic effects may be due to free-radical generation Tumorgenicity due to adsorption of potentially toxic substances on the fibers Initial injury occurs at the branch points of small airways and ducts
181
Morphology asbestos
Morphology Asbestosis: indistinguishable from diffuse interstitial fibrosis (honeycomb pattern) except for the presence of asbestos bodies In contrast to coal workers’ and silicosis, asbestosis begins in the lower lungs and works its way up. The scarring can cause pulmonary HTN and cor pulmonale Asbestos Bodies: pathognomonic, golden brown, fusiform or beaded rods 'dumbbell shaped' with translucent center and consist of asbestos fibers coated with iron-containing proteinaceous material Prussian Blue stain stains iron (saw this in GI with Wilson's disease) Arise via ingestion of asbestos fibers by macrophages Rarely single bodies can be found in healthy people aka Ferruginous Bodies Pleural plaques: well circumscribed plaques of dense collagen, no asbestos bodies, occur with exposure Most common manifestation of asbestos exposure Found on the anterior and posterolateral aspects of the parietal pleura and over the domes of the diaphragm Number and size of the plaques does not correlate with the level or time since exposure Rarely pleural effusions or visceral pleural fibrosis may occur and bind the lung to the thoracic wall localized pleural plaques are asymptomatic
182
Clincial asbestos
Clinically Dyspnea may occur as the first signs and symptoms 20-30 years after exposure cough associated with production of sputum is likely due to smoking rather than asbestosis CXR: irregular linear densities seen bilaterally in lower lobes (plaques) disease can be static or progress Honeycomb pattern with advanced pneumoconiosis Increased risk of lung cancer if also smoke cigarettes Grim prognosis with concurrent pulmonary/pleural malignancy
183
Drug induced lung disease
Drug Induced Lung Disease Cytotoxic drugs used in cancer therapy (e.g. bleomycin): pulmonary damage and fibrosis as a result of direct toxicity and by stimulating the influx of inflammatory cells into the alveoli Amiodarone: preferentially concentrated in the lung --> pneumonitis ACEI: cough ("very common") IV drug use → pulmonary infection particulate matter in IV drugs --> wedge in the pulmonary microvasculature --> granulomas and fibrosis
184
Radiation pneumonitis
well-known complication of therapeutic radiation of thoracic tumors (lung, esophageal, breast, mediastinal) Acute: Occurs 1-6 months post exposure lymphocytic alveolitis, hypersensitivity pneumonitis Fever, Dyspnea not proportional to area radiated Pleural effusion Infiltrates in an area of previous irradiation treatment: steroids
185
Chronic radiation pneumonitis
c: occurs if treatment does not take care of the acute pulmonary fibrosis Sequelae of the repair process of the damaged cells Diffuse alveolar damage (DAD) --> ARDS Severe atypia of hyperplastic type II cells and fibroblasts Epithelial cell atypia and foam cells in vessel walls
186
Sarcoidosis
efinition multi-system granulomatous disease of unknown etiology that can involve several organs and tissues Lung involvement or bilateral hilar lymphadenopathy in 90% of cases Diagnosis of exclusion non-caseating granulomas in various tissues from no identifiable cause only TB leads to caseating granulomas
187
Who gets sarcoidosis
Most common in patients < 40 US: common in the south 10x more likely in African Americans, rare in Chinese and Southeast Asians More common in females
188
Pathogenesis sarcoidosis
Accumulation of oligoclonal activated CD4+ T cells (5-15:1 CD4 to CD8) Increased TH1 cytokine production (IL2, IFN-γ) causing T cell expansion and macrophage activation Increased TNF, IL-8, and macrophage inflammatory protein 1α --> granuloma formation Bronchoalveolar TNF level is a marker for disease activity Cutaneous anergy to common skin test antigens (tuberculin, candida) Polyclonal hypergammaglobulinemia
189
Genetic factors sarcoidosis
HLA-A1, HLA-BB (class I)
190
Morphology sarcoidosis
well-formed, non-necrotizing granulomas with tightly clustered epithelioid macrophages and giant cells Granulomas may become enclosed within fibrous rims or may eventually be replaced by hyaline fibrous scars Can coalesce and make small, non-cavitated, noncaseating nodules, located mostly along the lymphatics around bronchi and blood vessels high frequency of granulomas in the bronchial submucosa accounts for the high diagnostic yield of bronchoscopic biopsies Schaumann bodies: Laminated, calcified proteinaceous concretions characteristic of granulomatous disease, not pathognomonic Asteroid bodies: Stellate inclusions within giant cells characteristic of granulomatous disease, not pathognomonic The lesions are likely to heal in the lungs and there are often various stages of fibrosis or hyalinization present
191
Lymph nodes sarcoidosis
I nvolved in almost all cases, especially the hilar and mediastinal nodes Enlarged, discrete, and sometimes calcified Tonsils can be affected too
192
Spleen and liver sarcoidosis
S cattered granulomas, especially around the portal triads
193
Bone marrow sarcoidosis
Lesions with phalangeal predilection Small circumscribed areas of bone resorption within the marrow creating a diffuse reticulated pattern with widening of the shafts or new bone on the outer surfaces
194
Skin sarcoidosis
Discrete subcutaneous nodules or erythematous scaling plaques
195
URI sarcoidosis
Mucus membrane lesions
196
Eye sarcoidosis
Iridocyclitis: may lead to corneal opacities, glaucoma, and total loss of vision Decreased lacrimation from inflammation
197
Mikulicz syndrome
Bilateral sarcoidosis of the major salivary glands (parotid, submaxilllary, sublingual) Sounds like mucus? So therefore saliva
198
Muscle sarcoidosis
May be asymptomatic Myopathy: weakness, aches, tenderness, fatigue
199
Other locations for granulomas in bod (sarcoidosis0
Heart, kidney, CNS, endocrine glands (espicially pituitary)
200
Clincial sarcoidosis
linically May be collateral finding, or patient may present with respiratory abnormalities or constitutional signs and symptoms (i.e. fever, fatigue, weight loss, anorexia, night sweats) Diagnosed via biopsy: non-caseating granulomas rule out other diagnosis based on cultures and stains -- sarcoidosis == diagnosis of exclusion Unpredictable course 65-70% recover with minimal or no residual manifestations 20% have permanent loss of some lung function or some permanent visual impairment 10-15% some die of cardiac or central nervous system damage; most succumb to progressive pulmonary fibrosis and cor pulmonale
201
Hypersensitivity pneumonitis
Spectrum of immunologically-mediated interstitial disorders due to inhaled organic antigens Primarily affect the alveoli -- extrinsic alveolar alveolitis
202
Types of hypersensitivity pneumonitis
F armers lung: actinomycetes spores in hay (thermophilic bacteria) Pigeon breeders lung: proteins from bird feathers or excreta Humidifier/AC lung: bacteria in heated H2O reservoir
203
Immune reaction hypersensitivity pneumonitis
Acute phase: proinflammatory chemokines (macrophage nflammatory protein 1a, IL-8) Increased CD4+ and CD8+ T lymphocytes Antibodies to causative agent in serum Complement and immunoglobulins in vessel walls
204
Morphology hypersensitivity pneumonitis
Interstitial pneumonitis and interstitial fibrosis of the bronchioles Noncaseating granulomas in 2/3 of patients == T-cell mediated (Type IV) hypersensitivity reactions Early cessation of exposure can prevent progression to serious chronic fibrosis and honeycomb lung Intra-alveolar infiltrate
205
Clinical hypersensitive pneumonitis
Variable clinical presentation Acutely: recurring fever, dyspnea, cough, leukocytosis 4-6 hours after exposure that may last for days CXR: micronodular interstitial infiltrates Pulmonary Function Tests indicate restrictive lung disease (FEV1:FVC ratio is normal) Progressive exposure: respiratory failure, dyspnea, cyanosis and decrease in total lung capacity and compliance
206
Pulmonary eosinophilia
Increased IL-5 levels attract eosinophils "5Always and 4Ever" except 5 also attracts eosinophils… Relatively rare
207
Acute eosinophilic pneumonia with respiratory failure
Unknown etiology Rapid onset fever, dyspnea and hypoxemic respiratory failure CXR: diffuse infiltrates Broncheolar lavage > 25% eosinophils Diffuse alveolar damage (DAD) == histologic feature of ARDS Prompt response to corticosteroids
208
Secondary eosinophilia
``` Induced by Infection (parasitic, fungal, bacterial) Hypersensitivity pneumonitis Drug allergies Association with asthma, allergic bronchopulmonary aspergillosis or Churg-Strauss Syndrome (vasculitis, asthma, MPO-ANCA/p-ANCA ```
209
Idiopathic chronic eosinophilic pneumonia
Unknown etiology diagnosis of exclusion Focal lung consolidation with extensive lymphocyte and eosinophil infiltration into the walls and the alveolar spaces Cough, fever, night sweats, dyspnea, weight loss Steroid responsive
210
Smoking related interstitial disease
Ok
211
Desquamative interstitial pneumonia ==DIP (past or present smoker disease)
Large, patchy collections of "Smoker's Macrophages" in alveoli of a current or former smoker
212
DIP morphology
Smoker’s Macrophage: lots of cytoplasm with dusty brown pigment and granular iron; lamellar bodies composed of surfactant inside phagocytic vacuoles Alveolar septa are thickened by a sparse inflammatory infiltrate of lymphocytes, plasma cells, and a few eosinophils Alveolar septa are lined by plump, cuboidal pneumocytes If there is any interstitial fibrosis, it is mild Emphysema is typically present
213
Clincial DIP
4-5th decade, no gender preference Insidious onset of dyspnea + dry cough over weeks to months Digit clubbing Pulmonary Function Tests: mild restrictive disease with moderate reduction in diffusing capacity Excellent response to steroids and smoking cessation
214
Respiratory bronchiolitis associated interstitial lung disease
Gradual dyspnea and cough of current smokers in their 4th - 5th decade Peribronchiolar inflammation and fibrosis
215
Morphology respiratory bronchiolitis associated interstitial lung disease
Patchy bronchiolar accumulations of "Smoker’s Macrophages" in 1st and 2nd order respiratory bronchioles Can also be found in the alveolar ducts Mild peribronchiolar fibrosis is seen that expands the contiguous alveolar septa Centrilobular emphysema is common, but not severe Desquamative interstitial pneumonia is often found in different parts of the same lung
216
Clinical respiratory bronchiolitis associated interstitial UAG disease
Insidious onset of dyspnea + dry cough over weeks to months | Smoking cessation = improvement
217
Pulmonary langerhans cell histiocytosis
R are disease of young adult smokers Most cases resolve with smoking cessation -- suggests that the lesions are a reactive inflammatory process Focal collections of Langerhans cells (and eosinophils) Langerhans Cells -- immature resident dendritic cells Airway destruction and alveolar damage leads to irregular cystic spaces CXR: cystic and nodular abnormalities Positive for S100, CD1a, CD207 (langerin), and are negative for CD68 Langerhans cells may acquire a BRAF mutation that can lead to a neoplastic process that requires lung transplant
218
Pulmonary alveolar proteinis (PAP)
Rare entity characterized by surfactant accumulation in alveoli and bronchioles Defects related to GM-CSF or pulmonary macrophage dysfunction Accumulation of surfactant in intraalveolar and bronchiolar spaces CXR: bilateral patchy, asymmetric pulmonary o
219
Types of pulmonary alveolar proteinosis
Autoimmune Secondary Hereditary
220
Autoimmune pulmonary alveolar proteinosis
Autoantibodies against GMCSF cause a functional deficiency, impairing surfactant clearance by macrophages Primarily occurs in adults 90% of all PAP cases No familial predisposition
221
Secondary pulmonary alveolar proteinosis
Uncommon Associated with many diseases that may impair macrophage maturation or function causing inadequate clearance of surfactant from alveolar spaces May follow exposure to irritating dusts/chemicals or in immunocompromised patients
222
Hereditary pulmonary alveolar proteinosis
Occurs in neonates and is rapidly fatal Mutations of GMCSF production or signaling Extremely rare
223
Morphology pulmonary alveolar proteinosis
Morphologically Alveoli are filled with granular pink precipitate composed of surfactant proteins Also contain cholesterol clefts Periodic Acid-Schiff (PAS) positive -- PAP is PAS positive Consolidation of large areas of the lungs with minimal inflammation Marked Increased in size and weight of the lungs Surfactant lamellae in type II pneumocytes are
224
Clincial Pap
Cough with abundant sputum containing chunks of gelatinous material -- pathognomonic Signs and symptoms may last years with febrile illness High risk for development of 2° infection Progressive dyspnea, cyanosis, and respiratory insufficiency may occur May also be benign with resolution of lesions Treatment: whole lung lavage regardless of underlying defect and GMCSF therapy
225
Surfactant dysfunction disorders
Ok
226
Surfactant dysfunction disorder mutation
Collection of mutations that leads to problems with surfactant
227
ATP binding cassette protein member 3 (ABCA3)
Autosomal recessive, presents in 1st months with rapidly progressive respiratory failure leading to death Sometimes found in older kids and adults that have chronic interstitial lung disease Small lamellar bodies with electron dense cores are diagnostic Most commonly mutated surfactant gene
228
Surfactant protein B
Autosomal recessive, infant is full term but rapidly develops progressive respiratory distress shortly following birth; death at 3-6 months Lack of surfactant protein B
229
Surfactant protein c
Autosomal dominant with variable penetrance and clinical course Second most common mutation Lack of surfactant protein C
230
Morphology surfactant dysfunction disorder mutations
Variable amount of intra-alveolar granular material, type II pneumocyte hyperplasia, interstitial fibrosis, and alveolar simplification Abnormalities in lamellar bodies in type II pneumocytes
231
Diseases of vascular origin
Ok
232
Large vessel pulmonary thrombosis
Rare | Develop in presence of pulmonary HTN, pulmonary atherosclerosis, and heart failure
233
Pulmonary embolism : who and what
Common in bedridden patients or those with predisposing hypercoagulability occur in 30% of severe burns, trauma, or fracture patients occur in 10% of patient who die acutely in hospitals DVT responsible for 95% of cases
234
Pulmonary embolism:pathogenesis
Occur in patient predisposed to clotting Cardiac disease, cancer, prolonged immobilization, hip fracture, hypercoagulability (factor V Leiden), oral contraceptives/pregnancy, obesity, IV lines Response depends on extent of obstruction, size of occluded vessel, number of emboli, CV status and release of vasoactive factors from platelets at thrombosis site Leads to respiratory compromise and/or hemodynamic compromise
235
Morphology pulmonary embolism
Morphology If the emboli are small enough to travel to the peripheral vessels, then it can cause hemorrhage if there is still adequate blood flow to the area or infarct if the patient has compromised cardiovascular function Most of the time the infarcts occur to the lower lobes and there are multiple lesions The infarcts take on a wedge with the apex pointing towards the hilum where the embolus is lodged Look for lines of Zahn on autopsy to know if it post-mortem vs. ante-mortem lines of Zahn present == ante-mortem Septic infarcts: if there are pathogens in the embolus then it will cause there to be neutrophils present
236
Pulmonary embolism: appearance of the infarct over time
pulmonary infarct is classically hemorrhagic and appears red-blue in early stages with the apposed pleural surface covered by a fibrinous exudate -- overlying fibrinous pleuritis --> pleural friction rub The RBCs begin to lyse within 48 hours and leads to infarct to become paler and red-brown as hemosiderin is produced Eventually there is fibrous replacement that begins at the margins as a gray-white peripheral zone and is eventually converted into a contracted scar
237
Clincial pulmonary embolism : large
Large Pulmonary Embolus Instantaneous death due to electromechanical dissociation: EKG has rhythm but no blood is entering pulmonary circulation so there is no pulse If the patient lives, then they may appear as though they are having an MI with severe chest pain, dyspnea, and shock
238
Clincial pulmonary embolism: Small
S mall-medium Pulmonary Emboli | Can have similar effects as large emboli but are more likely to be clinically silent
239
Clincial pulmonary embolism
Present as transient chest pain, hemoptysis, cough, fever May eventually have fibrinous pleuritis that can produce a friction rub CXR: there may be a wedge shaped infiltrate 12-36h after the infarct DVTs are diagnosed by duplex ultrasound If enough occur and heal to cause contraction, there can be pulmonary HTN and cor pulmonale
240
Prophylactic treatment pulmonary embolism
Important prophylactic therapy in patients who have had PE to prevent recurrence anti-coagulation therapy to prevent future clots; fibrinolytic therapy to break apart current clots If not possible patient should receive an IVC filter to prevent clots from reaching the lungs
241
Pulmonary HTN
Mean pulmonary artery pressure>25mmHg at rest
242
Five WHO classifications pulmonary HTN
Five WHO Classifications pulmonary arterial hypertension -- diverse collection of disorders that all primarily impact small pulmonary muscular arteries pulmonary hypertension secondary to left-heart failure pulmonary hypertension stemming from lung parenchymal disease or hypoxemia chronic thromboembolic pulmonary hypertension pulmonary hypertension of multifactorial basis
243
Cause of pulmonary HTN
e due to: Chronic obstructive or interstitial disease (group 3) Antecedent congenital or acquired heart disease (group 2) e.g. mitral stenosis Recurrent thromboemboli (group 4) Autoimmune disease (group 1) e.g. systemic sclerosis (scleroderma) Obstructive sleep apnea (group 3) --> pulmonary hypertension and cor pulmonale associated with obesity and hypoxemia Idiopathic or familial up to 80% of idiopathic pulmonary HTN has a genetic basis (autosomal dominant
244
Familial pulmonary HTN
Bone Morphogenetic Protein Receptor Type 2 (BMPR2): inhibits proliferation, favoring apoptosis first mutation to be discovered in familial pulmonary HTN inactivating mutations are found in 75% of familial cases and 25% of sporadic cases other mutations that converge on the BMPR2 pathway have also been found Mutations lead to vascular smooth muscle hyperplasia and increased vascular resistance Environmental influence or maybe 2-hit is needed to cause diseas
245
Secondary pulmonary HTN
Endothelial dysfunction leads to Increased vascular tone Promotes thrombosis Increased production of cytokines that promote smooth muscle cell proliferation and/or matrix synthesis
246
Morphology pulmonary HTN
Pul monary HTN: Morphology pulmonary artery atherosclerosis Medial hypertrophy of pulmonary muscular and elastic arteries, especially the arterioles and small arteries Right Ventricular Hypertrophy Plexiform lesions: Tufts within capillary channels produce a vascular plexus that spans the lumens of dilated, thin-walled, small arteries that may go outside the vessel Found with 1° pulmonary HTN, HIV (both group 1) and congenital CV anomalies (L2R shunts) (group 2) Numerous organized thrombi (indicate PE
247
Clinical pulmonary HTN
Idiopathic is most common in women 20-40 years old Evident only with advanced disease Progresses to severe respiratory insufficiency and decompensated cor pulmonale (+/- superimposed thromboembolism, pneumonia) Death from decompensated cor pulmonale, often with superimposed thromboembolism and pneumonia, usually ensues within 2-5 years in 80% of patients Treatment: vasodilation and lung transplantation
248
Diffuse pulmonary hemorrhage syndromes
use Pulmonary Hemorrhage Syndromes Goodpasture syndrome: lung and kidney disease, anti-BM antibodies Wegener's polyangiitis with granulomatosis == lung and kidney disease, but with PR3-ANCA/c-ANCA Idiopathic pulmonary hemosiderosis Vasculitis-associated hemorrhage found in conditions such as hypersensitivity angiitis, Wegener granulomatosis (polyangiitis with granulomatosis), and systemic lupus erythematosus
249
Goodpasture syndrome
Autoantibodies against the non-collagenous domain of collagen IV α3 chain (anti-Basement Membrane) Basement membrane destruction in renal glomeruli and pulmonary alveoli Rapidly progressive glomerulonephritis + necrotizing hemorrhagic interstitial pneumonitis Teens to late 20s, especially males Common in active smokers
250
Good pasture risk factors
Smoking, dry cleaning, viral infection | HLA-DRB1*1501 and *1502
251
Morphology good pasture
Heavy lungs with areas of red-brown consolidation Lungs with focal alveolar wall necrosis Intraalveolar hemorrhage + hemosiderin laden macrophages Later: fibrous thickening of the septae, hypertrophy of type II pneumocytes, and organization of blood in the alveolar spaces Immunofluorescence shows linear Ig depositions along septal basement membranes -- renal throwback
252
Clincial good pasture
Hemoptysis with focal pulmonary consolidations on CXR (necrotizing interstitial pneumonitis) also hematuria from the rapidly progressive glomerulonephritis (RPGN) Most common cause of death: uremia Treatment: plasmapheresis + immunosuppression therapy should ameliorate lung hemorrhage and glomerulonephritis will emergently perform plasmapheresis in the middle of the night
253
Idiopathic pulmonary hemosiderosis
``` Etiology unknown disease of children Intermittent diffuse alveolar hemorrhage Present with cough + hemoptysis similar to Goodpasture syndrome but there are no anti-basement membrane antibodies detected in serum Treatment: long-term immunosuppression Favorable response Long term patients may develop other immune disorders ```
254
Polyangitis with granulomatosis (Wagner’s)
PR3-ANCA/ c-ANCA (pr-thrEE cEE; C is the 3rd letter of the alphabet) Autoimmune disease Present with hemoptysis most often involves the upper respiratory tract and/or lungs transbronchial lung biopsy might provide the only tissue available for diagnosis Capillaritis -- this is a vasculitis, after all Scattered, poorly formed granulomas (sarcoidosis has well defined granulomas) granulomas with variable necrosis
255
Pulmonary infections: local defense compromise
``` Loss or suppression of the cough reflex Injury to the mucociliary apparatus Accumulation of secretions Interference with phagocytosis or bactericidal actions of alveolar macrophages Pulmonary congestion and edema ```
256
Pyogenic bacterial infections
Incidence increases when defects in innate or humoral immunity are present May also be due to MyD88 germline mutation MyD88 == adaptor for several TLRs that are important for activation of NFκB
257
Intracellular microbe infection
Defects in cell mediated immunity can lead to this type of infection Includes mycobacteria, herpes, and pneumocystis jiroveci pneumocystis jiroveci == low virulence
258
Most common cause of death with pulmonary infections
Most common cause of deaths in influenza epidemics == superimposed bacterial pneumonia
259
Community acquired pneumonia
Co mmunity Acquired Acute Pneumonia Lung infection in otherwise healthy individuals acquired from the normal environment Bacterial or viral Bacterial Infection Increased CRP and procalcitonin levels -- these are acute phase reactants (IL-6) Often follows a viral URI Causes alveoli to be filled with inflammatory exudate causing consolidation of pulmonary tissue Predisposition: age extremes, chronic disease (CHF, COPD, DM), congenital or acquired immunodeficiency, compromised splenic function (Sickle Cell Anemia or Trait)  
260
Strep pneumonia
Most common cause of community acquired pneumonia; distribution of inflammation is lobar Diagnosis: examine gram stained sputum Gram +ve, lancet-shaped diplococci; encapsulated Endogenous flora in 20% of adults, beware of false-positives isolation of pneumococci from blood cultures is more specific but less sensitive (on 20-30% of patients have positive blood cultures in the early phase of illness) Vaccines for those at high risk contain capsular polysaccharides from common serotypes
261
Haemophilus influenzae
Most common bacterial cause of acute exacerbation of COPD Pleomorphic, gram -ve Encapsulated or unencapsulated six serotypes of encapsulated: A through F (Type B is the most virulent) capsular polysaccharide b is incorporated in the widely used vaccine
262
Haemophilus influenza can lead to what
Pink eye Lower respiratory infection and suppurative meningitis in children (vaccine) Older patients: septicemia, endocarditis, pyelonephritis, cholecystitis, and suppurative arthritis
263
Unencapsulated haemophilus influenza (non typeable)
Unencapsulated Haemophilus influenzae (aka non-typeable) Less virulent Spread along the surface of the upper respiratory tract Can lead to: Otitis media Sinusitis Bronchopneumonia Kids are at more risk if they are premature or have cancer
264
HEMOPHIIUS INFLUENZA PNEUMONIA
Can follow a viral URI Pediatric emergency High mortality rate Descending laryngotracheobronchitis can lead to airway obstruction Small bronchi are plugged with dense, fibrin rich exudates with neutrophils Lobular, patchy consolidation (may become confluent and involve the entire lung lobe
265
Moraxella catarrhalis pneumonia
Bacterial pneumonia commonly in the elderly second most common bacterial cause of COPD exacerbation Otitis media in children associate with COPD and upper respiratory infection
266
Three most common causes of otitis medi
Streptococcus Pneumoniae: gram +ve, lancet shaped diplococci Haemophilus Influenzae: gram -ve, pleomorphic grown on chocolate agar (along with Legionella) Moraxella Catarrhalis:   Staphylococcus aureus pneumonia 2° bacterial pneumonia in children and healthy adults post-viral respiratory illness children: following measles children and adults: following influenza Several complications: Lung abscess, empyema IV drug users are at increased risk in association with endocarditis Often hospital acquired pneumonia (nosocomial) usually secondary to viral respiratory infections
267
Klebsiella pneumonia
Most frequent cause of gram (-) bacterial pneumonia Affects debilitated patients, chronic alcoholics, and malnourished individuals -- especially chronic alcoholics Three A's: Alcoholics, Aspiration, Abscesses *thick, mucoid (blood tinged) sputum -- "Currant jelly sputum" -- Buzzwords for Boards Organism produces viscid capsular polysaccharide, difficult to expectorate
268
Pseudomonas aeruginosa pneumonia
Pseudomonas aeruginosa pneumonia Common cause of nosocomial infection Invades blood vessels to spread systemically Common in cystic fibrosis, burn patients, and patients with neutropenia
269
Legionella pneumonia pneumonia
egionella pneumophila pneumonia Causative agent of Legionnaire's disease and Pontiac fever Flourishes in artificial aquatic environments (e.g. HVAC systems) Spreads through aerosolization or aspiration of contaminated water Severe pneumonia in immunocompromised patients, especially patients who have had organ transplant (50% fatal) -- "seen particularly in organ transplant recipients" Diagnose: culture (gold standard), antigens in urine, or antibodies in sputum lobar pattern on CXR, pulse-temperature dissociation lives in amoebas "like mycobacterium tuberculosis, this is a facultative intracellular parasite (lives in macrophages and free living amoebas)" grown on chocolate agar; use a silver stain to detect; urine antigens urine antigens == legionella, streptococcus pneumoniae can enter a low-metabolic state and survive in a biofilm
270
Mycoplasma pneumonia ==walking pneumonia
Sporadic infection or as local epidemics in closed communities such as schools, military camps, or prisons Common in children and young adults "walking pneumonia" "cold agglutinants" "bullous myringitis" -- Bullous myringitis is an infection of the tympanic membrane (the eardrum). Small fluid-filled blisters form on the eardrum and cause severe pain.  
271
Morphology lobular bronchopneumonia
Patchy exudative consolidation of the lung parenchyma Focal areas of palpable consolidation that are typically bilateral and basal Well-developed lesions are slightly elevated, dry, granular, grey-red to yellow, and poorly demarcated at the margins Acute neutrophilic suppurative exudation filling bronchi, bronchioles and alveoli that eventually resolves CXR: focal opacities
272
Morphology lobar pneumonia
Consolidation of a large portion of a lobe or an entire lobe CXR: whole lobe is radiopaque streptococcus pneumoniae == most common cause of community-acquired acute pneumonia and the pattern of inflammation is lobar Four Stages of Inflammation Congestion: heavy, boggy, red lung; vascular engorgement, alveolar fluid with few neutrophils and lots of bacteria Red hepatization: massive neutrophilic exudation with RBCs and fibrin that fill the alveolar spaces red, firm, and airless with a liver like consistency Grey hepatization: progressive disintegration of red cells and persistence of fibrinosuppurative exudate that leads to a grey-brown color sequelae of red hepatization Resolution: progressive enzymatic digestion of exudates --> granular, semifluid debris that is resorbed, ingested by macrophages, expectorated, or organized by fibroblast growing into it. May even extend to the surface as pleuritic
273
Pneumonia complciations
``` Abscess formation (especially from Type 3 pneumococci or klebsiella) due to tissue destruction and necrosis Empyema: intrapleural fibrosuppurative reaction infection spreads into pleural cavity causing fibrinosuppurative reaction Bacteremic dissemination to heart valves, pericardium, brain, kidneys, spleen, etc. --> endocarditis, meningitis, suppurative arthritis, etc ```
274
Community acquired bacterial pneumonia clincial
Abrupt onset of high fever, shaking chills (rigors), productive cough, and occasional hemoptysis Pleural involvement: pleuritic chest pain + friction rub treatment: antibiotics change course of disease within 48-72 hours  
275
Community acquired viral pneumonia
Alveoli fluid transudation Upper airways loss of normal mucociliary clearance can predispose to 2° infection interstitial infiltrates
276
Morphology community acquired viral pneumonia
Patchy or lobar areas of congestion without consolidation (atypical) Interstitial pneumonitis occurs with widened, edematous alveolar walls and mononuclear inflammation Hyaline membranes = diffuse alveolar damage Cytopathic changes may occur, including cell death and secondary inflammation
277
Influenza virus
Single stranded RNA virus with 8 strands bound by a nucleoprotein that determines the virus type (A, B or C) Hemagglutinin (H1-3) attach virus to target cells via sialic acid residues on surface polysaccharides antibodies against hemagglutinin prevent infection "glue attaches things" Neuraminidase (N1-2) facilitate release of newly formed virions that are budding from infected cells by cleaving sialic acid residues antibodies against neuraminidase ameliorate infection (Tamiflu) "is the other one" Type A infects humans, pigs, horses, and birds and are the major cause of pandemics and epidemics Type B and C do not mutate, so childhood infection conveys life-long antibody protection
278
Influenza epidemic
due to mutation in hemagluttinin and neuraminidase proteins (antigenic drift constant because viral RNA polymerase lacks proofreading capability) that create new viral strains which elude antibodies produced to prior exposure to other strains New strains bear some resemblance to prior strains and there is often some resistance to infection in some patients
279
Influenza pandemic
Hemagluttinin and neuraminidase genes are replaced due to recombination of influenza virus with animal influenza viruses (antigenic shift) All individuals are susceptible to the new virus as it is a completely new viral strain
280
Pathogenesis influenza virus
Hemagluttinin and neuraminidase genes are replaced due to recombination of influenza virus with animal influenza viruses (antigenic shift) All individuals are susceptible to the new virus as it is a completely new viral strain Pathogenesis Enters pneumocytes, inhibits Na+ channels which leads to electrolyte and water in the alveolar lumen Death of infected cells via mRNA translation + apoptosis which exacerbates fluid accumulation Releases "danger signals" activating resident macrophage Induces release of inflammatory mediators Nearby pulmonary endothelium is activated allowing neutrophil extravasation into the interstitium May cause ARDS or lead to 2° bacterial pneumonia Staphylococcus aureus superimposed on top of influenza infection can cause life-threatening 2° pneumonias
281
H5N1
high mortality rate -- the virus is deadly transmission is inefficient -- fear is that it will recombine with a highly virulent strain (H1N1, swine flu) Spread through wild and domestic birds -- Avian Flu Is spread throughout the body, not confined to the lung -- systemic Tropism of the hemagluttinin protein is due to ability to be cleaved by diverse proteases, where most are only cleaved in the lung
282
Human metapneumovirus
Paramyxovirus Associated with upper and lower respiratory infections Causes bronchiolitis and pneumonia in the young, old, and immunocompromised clinically indistinguishable from those caused by human respiratory syncytial virus RSV == #1, MPV == #2 -- clinically, they look exactly the same occurs in early childhood and reinfection is common throughout life treatment for immunocompromised patients with ribavirin (anti-viral agent) no current vaccine
283
Severe acute respiratory syndrome
Coronavirus that infects the lower respiratory tree and spreads systemically Appeared suddenly in 2002 in China and has not been seen since 2004 Transmitted through respiratory secretions Dry cough, malaise, myalgia, and fever 1/3 recover, remainder progress to severe respiratory disease, 10% die Fatal cases have diffuse alveolar damage + multinucleated giant cells  
284
Viral infection: morphology
URI with mucosal hyperemia, swelling, lymphomonocytic and plasmacytic infiltration of submucosa, mucus overproduction which may plug sinuses or Eustachian tubes leading to suppurative 2° bacterial infection Viral tonsillitis is common in kids resulting in hyperplasia within the Waldeyer ring Lung involvement: red-blue areas with congestion Interstitial inflammatory reaction involving walls of the alveoli causing wide alveolar septa If complicated by ARDS, pink hyaline membranes line alveolar walls
285
Viral laryngotracheobronchitis and bronchiolitis
Vocal cord swelling and abundant mucus production Bronchocilliary impairment invites 2° infection Focal lung atelectasis due to plugging of small airways (obstruction --> resorption atelectasis) Fibrosis may result if presence of exudates in terminal airways is prolonged and can lead to obliterative bronchiolitis and permanent lung damage superimposed bacterial infection may cause ulcerative bronchitis and bacterial pneumonia
286
Clincial influenza infection
Lung infection can be patchy or extensive involved areas are red-blue and congested interstitial inflammatory reaction involving the alveolar wall tissue with edema + lymphocytes and macrophage Disease extent depends on host immune status, virulence of infecting strain and presence/absence of other complicating factors Variable progression with headache, fever, muscle aches/pains in legs Few localizing signs and symptoms, and may masquerade as URI or chest colds Edema and exudation cause V/Q mismatch causing signs and symptoms out of proportion to scant physical findings Usually mild and resolve spontaneously
287
Heath care associated pneumonia risk factors
Recent hospitalization of 2+ days Presentation from a nursing home/long term facility Attending hospital/hemodialysis clinic Recent IV antibiotic therapy, chemotherapy or wound care More commonly infected with methicillin resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa Increased mortality vs. community acquired pneumonia
288
Hospital acquired pneumonia
Pulmonary infection acquired in the course of a hospital stay Increased risk with underlying disease, immunosuppression, prolonged antibiotic therapy, invasive access devices Very increased risk if patient is on mechanical ventilation (Gram -ve bacilli) Most commonly caused by: Gram +ve cocci: Staphylococcus Aureus and Streptococcus Pneumonia Gram -ve rods: Enterobacteriaceae and Pseudomonas Gram -ve bacilli: ventilator associated pneumonia
289
Aspiration pneumonia
``` Occurs in markedly debilitated patients with abnormal gag and swallowing reflexes Pneumonia is chemical + bacterial Aerobes > anaerobes Fulminant necrotizing pneumonia Frequent cause of death Complication in survivors: lung abscess Klebsiella ```
290
Micro aspiration
Occurs in almost all people, especially in patients with GERD Results in inconsequential poorly formed non-necrotizing granulomas Multinucleated foreign body cell reaction May exacerbate preexisting lung diseases like asthma, interstitial fibrosis, and lung rejection
291
Lung (pulmonary) abscess
Local suppurative necrosis of lung tissue Air fluid levels are very characteristic
292
Lung abscess common pathogens
Streptococci, Staphylococcus Aureus, many gram -ve organisms Commonly mixed infection due to aspiration which means many anaerobic oral cavity organisms (Bacteroides, Fusobacterium, Peptococcus *60%)
293
Other causes lung abscess
Antecedent primary lung infection from things like Staphylococcus aureus, Klebsiella pneumoniae, and type 3 pneumococcus Septic embolism Neoplasia obstructing the bronchopulmonary segment Bacteria spreading from somewhere else in the bod
294
Location of abscess based on cause
Aspiration based ones are more common on the right and single Pneumonia based abscesses are typically located basally and are found in multiple diffusely scattered Septic based abscesses are multiple and can involve any region of the lung
295
Morphology lung abscess
Single or multiple Microscopic to large cavities Histology: suppurative destruction of the lung parenchyma within the central area of cavitation Pus or air depending on available drainage Chronically may be surrounded by a reactive fibrous wall surrounding large, poorly demarcated, fetid, green-black gangrene
296
Superimposed saprophytic infections are prone to develop within the necrotic debris
Ok
297
Clinical pulmonary abscess
Presents as cough, fever, chest pain, weight loss, and copious amounts of foul smelling purulent or sanguineous sputum bronchiectasis and lung abscess == foul smelling sputum Clubbing of the fingers can develop in a few weeks Can be complicated by extension into pleural cavity, hemorrhage, septic embolization, 2° amyloidosis Confirm with CXR treatment: antimicrobials resolve most cases with a scar
298
Primary cryptogenic lung abscess
When there is no discernible basis for the abscess formation
299
Chronic pneumonia
Localized inflammation in immunocompetent patients without regional lymph node involvement Asymptomatic Limited granulomatous disease In immunocompromised patients the infection can become disseminated Fulminant, widespread disease
300
Histoplasmosis capsulatum
Intracellular pathogen of phagocytes, endemic to Ohio and Mississippi river valleys (midwest) Acquired via inhalation of dust with bird/bat excreta (caves) bird can also --> hypersensitive pneumonitis Mainly only infects immunocompromised patients macrophages are the major target of infection
301
Types of infection progression (similar to Tb) in histoplasmosis capsulatum
Self-limited, latent, 1° pulmonary involvement which may result in coin lesions on CXR Chronic, progressive, 2° lung disease localized to the lung apices causing cough, fever, and night sweats Spread to extrapulmonary sites (e.g. mediastinum, adrenals, liver, meninges) widely disseminated disease in immunocompromised patients
302
Morphology histoplasma capsulatum
Produces granulomas with caseating, coagulative necrosis which undergo fibrosis and concentric calcification (tree-bark appearance) -- can eventually lead to bronchiectasis? Silver stain identifies 3-5 micron cysts of the fungus that can persist for years (and differentiates this fungus from tuberculosis) Fulminant disseminated histoplasmosis: Immunocompromised patients. Focal accumulations of mononuclear phagocytes filled with fungal yeasts throughout the body, NO granulomas for fungal infections, stain with silver or PAS 3-5 micrometer pear shaped intracellular yeast
303
Clinical histoplasma capsulatum
Look for the antigens in the tissues in the beginning and then antibodies after 2-6 weeks coin lesion differential: histoplasma, hamartoma, adenocarcinoma
304
Blastomyces dermatiditis
Soil dwelling, dimorphic fungus that occurs in central and southeast USA (Florida) also Canada, Mexico, Middle East, Africa, and India
305
Different forms of blastomyces dermatiditis
Pulmonary, disseminated or primary cutaneous (rare)
306
Clincial presentation of pulmonary blastomycosis
Usually upper lobe involvement with abrupt productive cough, head ache, chest pain, weight loss, fever, abdominal pain, night sweats, chills, and anorexia CXR: lobar consolidation, multi-lobar infiltrates, perihilar infiltrates, multiple nodules, miliary infiltrates Upper lobes are most commonly involved Typically resolves spontaneously
307
Morphology blastomyces dermatiditis
(BBBB) Blastomycosis: broad based budding Immunocompetent host: suppurative granulomas with persistence of yeast cells due to limited macrophage capabilities to kill this fungus 5- 15 micron yeast cells that divide by broad based budding Thick double-contoured cell wall with visible nuclei Involvement of the skin and larynx is associated with marked epithelial hyperplasia, can be mistaken for squamous cell carcinoma 5-15 micrometers yeast with broad based budding
308
Coccidioidomycosis
``` outhwest USA, Mexico deserts (Arizona) everyone who inhales the spores of Coccidioides immitis becomes infected and develops a delayed-type hypersensitivity reaction to the fungus Inhaled spores (arthroconidia) block fusion of the phagosome and lysosome in the macrophage and resist intracellular killing ``` Inhaled spores (arthroconidia) block fusion of the phagosome and lysosome in the macrophage and resist intracellular killing
309
Clincal coccidiodomycosis
Most cases are asymptomatic San Joaquin Valley Fever complex: 10% of infected people develop lung lesions, fever, cough, pleuritic pains, erythema nodosum, and erythema multiforme less than 1% of people develop disseminated Coccidioides immitis infection which involves the skin and meninges (Filipinos and African-Americans are at increased risk of disseminated disease
310
Morphology coccidioidomycosis
Within macrophages, the fungus is seen as thick-walled, nonbudding spherules 20-60 microns and filled with endospores Spherule rupture, releasing endospores causes a superimposed pyogenic reaction and may recruit neutrophils Lesions can be granulomatous or pyogenic or mixed, with the disseminated type favoring more of the pyogenic type 20-60 micrometer nonbudding spherules
311
Pneumonia int he immunocompromised host
Opportunistic infections rarely affect normal hosts, but in this setting can cause life-threatening pneumonia appearance of a pulmonary infiltrate, with or without signs of infection (e.g. fever), is serious in patients whose immune system is suppressed by disease, immunosuppressive therapy for transplant, chemotherapy, or irradiation Often multiple organisms are involved Bacteria: Pseudomonas, Legionella, Listeria, mycobacteria Viruses: CMV, herpes Fungi: Pneumocystis jiroveci (AIDS defining), Candida, Aspergillus, phycomycetes, Cryptococcus neoformans
312
Pulmonary disease in HIV
Serious issues can be caused by the "normal" lower respiratory infection pathogens (Streptococcus pneumonia, Staphylococcus aureus, Haemophilus influenza, gram -ve rods) the usual pathogens are among the more serious bacterial pneumonias in HIV patients are more common, more severe, and more often associated with bacteremia than in those without HIV infection Pulmonary disease may be due to multiple causes and signs and symptoms can be atypical Base on the Stage of Disease (HIV/AIDS) CD4+ > 200 = bacterial and tubercular infection CD4+ 50-200 = Pneumocystis -- AIDS defining illness CD4+ < 50 = CMV, fungal and Mycobacterium avium
313
Indications for lung transplant
Emphysema (pink puffer) [chronic bronchitis == blue bloater] -- not candidate for lung transplant Idiopathic pulmonary fibrosis == end stage lung, honeycomb lung Cystic Fibrosis 1° pulmonary HTN
314
Single or double lung transplant
Usually single
315
Infections lung transplant
Early are bacterial ganciclovir prophylaxis and matching of donor-recipient CMV status == reduced frequency and severity of CMV pneumonia (because everyone has CMV but nobody is sick with CMV) Most common 3-12 months post-operative Acute rejection: all patients to varying degrees despite immunosuppression If fungal: due to aspergillus and candida
316
Lung transplant rejection: acute
inflammatory infiltrates around small vessels or in the submucosa of airways Several weeks to months after surgery, but may also present years later Fever, dyspnea, cough, radiologic infiltrates Looks like infection, so need biopsy to rule out pathogens Inflammatory infiltrates
317
Lung transplant chronic rejection
Happens to at least 50% of patients after 3-5 years Cough, dyspnea, and irreversible decrease in lung function due to pulmonary fibrosis Bronchiolitis obliterans partial or complete occlusion of small airways by fibrosis +/- inflammation; patchy; difficult to treat
318
Tumors of th lung
90-95% carcinoma 5% bronchial carcinoid 2-5% mesenchymal and other miscellaneous
319
Lung cancer facts
Most frequently diagnosed major cancer in the world Most common cause of cancer mortality worldwide Mostly due to tobacco smoke Commonly occurs between 40-70 years old
320
Types of lung cancer
Small cell -- TB, TP53, and MYC Non-small cell Squamous cell -- RB, TP53, p40, hypercalcemia, keratin pearls and intercellular bridges Adenocarcinomas -- EGFR, ALK, ROS, MET, RET, KRAS
321
Tobacco and lung cancer
Females have Increased susceptibility to the associated carcinogens Risk of lung cancer is proportional to the amount and duration of smoking Cessation decreases risk after 10 years, but not to baseline Individuals with P450 polymorphisms have a greater risk of lung cancer due to activation of pro-carcinogens Increased chromosome breakage sensitivity in peripheral blood lymphocytes = 10x risk
322
Industrial hazard lung cancer
Asbestos (10-30 year latency, 5x risk, if smoker 55x) Arsenic Chromium Uranium (exposed miners 4x risk, if smoker then 10x risk) Nickel Vinyl chloride -- hepatic adenocarcinoma Mustard gas Ionizing radiation (Hiroshima, Nagasaki, Chernobyl
323
Air pollution lung cancer
Add to risk of lung cancer in those who smoke via inflammation and repair
324
Squamous cell carcinoma
Loss of tumor suppressor genes due to tobacco smoke exposure Loss of CDKN2A (3p, 9p) = loss of p16 (RB) Loss of TP53 (17p) *highest frequency of TP53 mutations of all histologic types of lung carcinoma highly associated with exposure to tobacco smoke and harbors diverse genetic aberrations, many of which are chromosomal deletions involving tumor suppressor loci (two hits needed) Loss of RB Amplification of FGFR1 More common in the central/hilar region of the lung squamous cell carcinoma is more common (20%) than small cell carcinoma (14%) keratin pearls and intercellular bridges
325
Small cell carcinoma
``` Strongest association with smoking TP53 loss of function (75-90%) RB mutations are most likely (~100%) in small cell carcinomas Chromosome 3p deletion MYC amplification Aggressive, high mortality ```
326
Adenocarcinoma
Gain-of-function of GF receptor signaling pathways Tyrosine kinases: EGFR, ALK, ROS, MET, RET, KRAS KRAS mutations are the worst More common in the peripheral lung Precursor lesions Atypical adenomatous hyperplasia (≤ 5mm) Adenocarcinoma in situ < 3 cm; mucinous, atypical cells
327
Lung cancer in never smokers
More common in women Most are adenocarcinomas More likely to have EGFR mutation, and almost never have KRAS mutations TP53 is less common than in those who smoke
328
Precursor lesion lung cancer
Squamous dysplasia and CIS Atypical adenomatous hyperplasia Adenocarcinoma in situ Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
329
Tumor classification
Via the predominant histologic appearance, though multiple histologies can be present in one tumor clinical significance is still undetermined four major histologic subtypes Adenocarcinoma (38%) Squamous cell carcinoma (20%) Small cell carcinoma (14%) treat with chemotherapy because almost all are metastatic at presentation Large cell carcinoma (3%) Other (25%)
330
Atypical adenomatous hyperplasia
Single or multiple, small lesion characterized by dysplastic pneumocytes lining alveolar walls that are mildly fibrotic In the lung adjacent to invasive tissue or away from it  
331
Adenocarcinoma in situ
Single (favorable) or multiple in the terminal bronchioloalveolar regions Composed entirely of dysplastic cells growing along preexisting alveolar septae lepidic? Excessive dysplasia (more than atypical adenomatous hyperplasia) Tall, columnar +/- intracellular mucin (mucinous vs. nonmucinous) No gender specificity, no association with smoking Dismal prognosis if diffuse tumors 3 cm or less in diameter characterized by pure growth along pre-existing structures (lepidic pattern) without stromal invasion lepidic == rind, skin, or membrane epithelium are normal, lining cells are abnormal
332
Adenocarcinoma
Most common lung cancer in the absence of smoking Common in the peripheral lung Malignant epithelial tumor with glandular differentiation or mucin production Grow in various patterns majority express thyroid transcription factor 1 (TTF-1) Lepidic pattern of spread as tumor cells crawl along pre-existing alveolar septa without stromal invasion Associated with TTF1 and napsin A Grow more slowly, but metastasize earlier vs. squamous cell carcinoma
333
Micro-invasive adenocarcinoma
Tumors ≤ 3cm with a small invasive component (≤ 5mm) Associated with scarring and peripheral lepidic growth pattern Better outcome vs. invasive carcinoma of comparable size
334
Mucinous adenocarcinoma
S olitary or multiple nodules Potentially consolidate an entire lobe with tumor cells resembling lobar pneumonia less likely to be cured with surgery Spread aerogenously forming satellite tumors
335
Squamous cell carcinoma
Commonly in men, strongly associated with smoking most common lung cancer associated with smoking because this is more likely than squamous cell cancer (20% vs 14%... not how stats work but OK) Antedated squamous metaplasia/dysplasia in the bronchial epithelium that transforms to CIS CIS is cytologically identifiable by sputum or lavage, but undetected on CXR and is asymptomatic Can grow to obstruct the bronchus causing distal atelectasis and infection May penetrate the wall of the bronchus and infiltrate peribronchial tissue
336
Histology squamous cell carcinoma
'Cauliflower' mass Grey/white, firm neoplastic tissue If there is hemorrhage or necrosis, they appear as red-yellow mottling and can cavitate Keratinization (squamous pearls) or intercellular bridges There is more that is seen in well differentiated tumors and is only focally present in undifferentiated tumors Increased mitotic activity in poorly differentiated tumors Closest correlation with smoking Commonly in the central/hilar region Associated with p53 and p40 markers Late metastases Surrounding tissue is typically dysplastic Paraneoplastic Syndromes == hypercalcemia
337
Paraneoplastic syndrome squamous cell carcinoma
Hypercalcemia
338
Small cell carcinoma
Highly malignant, metastasizing widely (high grade), almost always fatal Strongest lung cancer association with smoking Arises in the major bronchi or in the periphery of the lung -- central There is no known pre-invasive phase Small cells with scant cytoplasm, ill-defined borders, finely granular nuclear chromatin (salt & pepper) + lack of nucleoli Nuclear molding is prominent High mitotic count Don’t show glandular or squamous organization Necrosis is common and often extensive Azzopardi effect: Basophilic staining of vascular walls due to encrustation by DNA from necrotic tumor cells Cells may originate from neuroendocrine progenitor cells with dense-core neurosecretory granules Expression of chromogranin, synaptophysin, CD57, hormonal secretion (paraneoplastic) Lung cancer most commonly associated with ectopic hormone production BLC2 found on immunohistochemistry Paraneoplastic Syndromes == SIADH and Cushing (ectopic cortisol)  
339
Combined small cell carcinoma
Small cell carcinoma is mixed with non small cell histologies May resemble sarcoma
340
Large cell carcinoma
Undifferentiated malignant epithelial tumor lacking cytologic features of other lung cancers Diagnosis of exclusion Variant may express neuroendocrine components, but tumor cell size is much larger than small cell carcinoma Prominent nucleoli
341
Carcinoma spread
May extend onto the pleural surface, spread within the pleural cavity or into the pericardium Most cases (> 50%) metastasize to the bronchial, tracheal and mediastinal lymph nodes Lymphatic and hematogenous spread occurs Metastasize early except squamous cell carcinoma Metastasis may be the first manifestation 50% of metastatic cases involve the adrenals Other common sites include liver, brain and bone  
342
Combined carcinoma
Combined carcinoma Where there are more than 1 type of tumor cell present in the mass happens in approximately 10% of all lung carcinomas
343
Complications of carcinoma
partial obstruction --> focal emphysema total obstruction --> Atelectasis (resorption kind) impaired drainage --> Suppurative or ulcerative bronchitis or bronchiectasis Pulmonary abscesses Superior vena cava syndrome Pericarditis Pleuritis Invasion of neural structures near trachea → Horner syndrome *Pancoast tumors Partial Ptosis Anhidrosis Miosis (increase in sympathetics, constricted pupil
344
Lung cancer clinical course
Cough, weight loss, chest pain, dyspnea Poor prognosis, especially with metastasis (common to adrenals, brain, liver and bone) adenocarcinoma and squamous cell carcinoma tend to remain localized longer and have a slightly better prognosis than do the undifferentiated cancers, which are usually advanced by the time they are discovered small cell cancer (oat cell cancer) is virtually always fatal 5 year survival 52% if disease is localized at presentation 22% with regional metastases 4% with distant metastases Survival is prolonged if targeting adenocarcinoma that have the EGFR mutation -- just like breast cancer Survival is reduced if there is a KRAS mutation (worse prognosis) Small cell carcinoma: sensitive to radiation and chemotherapy if localized, but most patients present with metastases Pathoma: "so small the surgeon can't see it"
345
Lung cancer and paraneoplastic syndromes : small cell carcinoma
Small Cell Carcinoma SIADH: hyponatremia due to inappropriate/excess ADH secretion Cushing Syndrome: ACTH
346
Paraneoplastic syndromes with squamous cell arcinoma
Hypercalcemia: parathormone, parathyroid hormone-related peptide, PGE2, cytokines Hypocalcemia: calcitonin Gynecomastia: gonadotropins Carcinoid syndrome: 5HT, bradykinin, MEN1
347
Lambert Eaton myasthenic syndrome
Muscle weakness due to auto-antibodies directed against the neuronal Ca++ channel better with activity myasthenia gravis == fatigable ptosis (better with rest) Hypertrophic pulmonary osteoarthropathy (associated with clubbing of the fingers) Acanthosis nigricans Peripheral neuropathy (sensory) Leukemoid reaction Hypercoagulable states (Trousseau
348
Pancoast tumors
Apical Lung Cancer arising from the superior pulmonary sulcus tend to invade neural structures near trachea (cervical sympathetic plexus) Horner Syndrome: ptosis, miosis, anhidrosis -- "PAM is horny" Ipsilateral severe pain in ulnar nerve distribution
349
Neuroendocrine proliferation’s and tumors
Ok
350
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Precursor to the development of tumorlets and typical or atypical carcinoids tumorlet == small, inconsequential (benign), hyperplastic nest of neuroendocrine cells seen in areas of scarring or chronic inflammation carcinoids may occur in patients with multiple endocrine neoplasia (MEN) type 1 Rare disorder
351
Carcinoid tumors
Typical or atypical, low-grade malignant epithelial neoplasms Epidemiology < 40 years, no gender specificity 20-40% are nonsmokers
352
Morphology carcinoid tumors
May arise centrally or peripherally Central may protrude into bronchial lumen and are covered by an intact mucosa Peripheral are solid and nodular Organoid, trabecular, palisading, ribbon, or rosette-like arrangements of cells separated by a delicate fibrovascular stroma Cells are regular and have a uniform round nuclei and a moderate amount of eosinophilic cytoplasm Most are confined to mainstem bronchi May penetrate bronchial wall, fanning out 'collar button lesion'
353
Clincial carcinoid tumros
Coughing, hemoptysis, impaired drainage, bronchiectasis, emphysema, and atelectasis can all happen secondarily to the growing lesion Carcinoid syndrome: intermittent attacks of diarrhea, flushing, and cyanosis occurring in 10% of patients due to tumor secretion of vasoactive amines (5HT) 5 year, 95% survival for typical 5 year, 70% survival for atypical
354
Typica carcinoid tumor
Fewer than 2 mitosis/10 high powered fields
355
Atypical carcinoid tumor
``` Increased pleomorphism Prominent nuclei Increased mitotic activity Increased risk of lymphatic invasion 2-10 mitoses/10 high-powered fields and/or foci of necrosis ```
356
Lung hamartoma
Radio-opacity 'coin lesion’ on routine CXR coin lesions on CXR == histoplasma, lung hamartoma, adenocarcinoma Well circumscribed, solitary -- low-grade, benign? Nodules of connective tissue (cartilage, fibrous, fat) intersected by epithelial clefts Can be cancerous if associated with chromosome problems with 6 or 12
357
Lymphangioleiomyomatosis
Young women of childbearing age present with dyspnea or spontaneous pneumothorax Proliferation of perivascular epithelioid cells with markers of melanocytes and smooth muscle cells Cystic, emphysema like expansion of terminal airspaces, thickening interstitium and obstruction of lymphatic vessels lesional epithelioid cells appear to frequently harbor loss of function mutations in the tumor suppressor TSC2, one of the loci linked to tuberous sclerosis tuberin == negative regulator of mTOR (mutation leads to increased mTOR activity) mTOR plays a function in regulating metabolism Slow progression over several decades Definitive treatment: lung transplantation
358
Inflammatory myofibroblasts tumor
Children, no gender preference Fever, cough, chest pain, hemoptysis Grey/white, round, well defined single peripheral mass, with calcium deposits Proliferation of fibroblasts, myofibroblasts, lymphocytes, plasma cells Peripheral fibrosis Some have ALK mutation Treatment with ALK inhibitors have produced response  
359
Most common site of metastatic neoplas: lung
multiple discrete nodules (cannonball lesions) are scattered throughout all lobes, more being at the periphery
360
Pleura
Ok
361
Pleural effusion
Normally 15 ml of serous, acellular, clear fluid lubricates the pleural surface May occur due to Increased hydrostatic pressure (CHF) Increased vascular permeability (pneumonia) Increased negative intrapleural pressure (atelectasis) Decreased oncotic pressure (nephrotic syndrome) Decreased lymphatic drainage (carcinomatosis
362
Inflammatory pleural effusion
Associated with underlying pulmonary inflammation tuberculosis, pneumonia, infarct, abscess, systemic disease Fluid exudate is resorbed with resolution or organization of fibrinous components Respiratory distress may occur due to fluid accumulation compressing the lung
363
Suppurative pleuritis (empyema)
Reflects pleural space infection causing accumulation of pus (yellow, creamy
364
Cause of suppurative pleuritis (empyema)
Likely due to bacterial or mycotic seeding via spread from intrapulmonary infection Less frequently due to lymphatic or hematogenous spread from a distant source Rarely due to infection below the diaphragm (liver abscess), more common on the right side
365
Morphology suppurative pleuritis
Loculated, yellow-green, creamy pus with neutrophils and other leukocytes chylothorax == milky white Small, localized volume Commonly, organizes into dense, tough fibrous adhesions that obliterate the pleural space or envelop the lungs, significantly restricting pulmonary expansion
366
Hemorrhagic pleuritis
Sanguineous inflammatory exudates due to bleeding disorders, neoplasm, or rickettsial disease Look for exfoliated tumor cells Must differentiate from hemothorax
367
Hydrothorax
Noninflammatory pleural effusion within the pleural cavity Clear, straw-colored fluid unilateral or bilateral most common cause is cardiac failure, and thus it is often accompanied by pulmonary congestion and edema Usually due to heart failure, but also in renal failure and liver cirrhosis
368
Hemothorax
Noninflammatory pleural effusion Blood in the pleural cavity Fatal complication of ruptured aortic aneurysm or vascular trauma May occur post-operatively
369
Chylothorax
Noninflammatory pleural effusion Accumulation of milky fluid (often of lymphatic origin) pus is creamy and yellow Milky white due to emulsified fats due to thoracic duct trauma or obstruction causing secondary rupture of major lymphatic ducts, usually malignancies
370
Spontaneous idiopathic pneumothorax
Young patients Rupture of small, peripheral, usually apical sub-pleural blebs Subsides as air is resorbed Recurrent attacks may occur and are disabling
371
Tension pneumothorax
Defect between airways and pleura act as a one way valve Air enters during inspiration but is not released during expiration Progressively increasing pleural pressure compresses the contralateral lung and mediastinal structures (possibly fatal) trachea deviates away from the side of the tension pneumothorax
372
Pleural tumors
Usually metastatic tumors from the lung and breast Leads to serous or serous-sanguineous effusion that contains neoplastic cells careful cytologic examination of the sediment is of considerable diagnostic value
373
Solitary fibrous tumor
Noninvasive, solitary fibrous tumor Attached to pleural surface via a pedicle -- pedunculated? Small or large
374
Morphology solitary fibrous tumours
Solitary fibrous tumor with dense fibrous tissue with occasional cysts filled with viscous fluid Whorls of reticulin and collagen fibers with interspersed spindle cells resembling fibroblasts CD34 +ve and Keratin -ve malignant mesotheliomas show the opposite phenotype Inversion of chromosome 12 (NAB2 -STAT6 rearrangement) NAB2-STAT6 --> fusion gene virtually unique to solitary fibrous tumor hypothesized to be a key driver of tumor development No relation to asbestos exposure Resection is curative
375
Malignant mesothelioma ==cytokeratin +ve
Uncommon tumor of mesothelioma cells int he visceral or parietal pleura
376
Epidemiology malignant mesothelioma
90% of cases are related to asbestos exposure 25-45 year latency Smoking has no impact (< risk than lung carcinoma) Asbestos bodies and plaques may be seen
377
Mutations malignant mesothelioma
Chromosome 9: CDKN2A/INK4A deletion (tumor suppressor) | Chromosome p16 deletion
378
Morphology malignant mesothelioma
``` Tumor is spread diffusely over the lung surface and fissures to form an encasing soft, gelatinous, gray-pink tumor sheathe Three Patterns Epithelioid (60%) Sarcomatoid (20%) Biphasic/mixed (20%) ```
379
Epithelial malignant mesothelioma
Epithelium like cells form tubules and papillary projections resembling adenocarcinomas with cuboidal, columnar, or flattened cells +ve for cytokeratin proteins, calretinin, WT1 (Wilms Tumor), cytokeratin 5/6 and D2-40 opposite of a solitary fibrous mass
380
Sarcomatoid pattern malignant mesothelioma
Sarcomatoid Pattern Malignant, spindle-shaped cells resembling a fibrosarcoma Lower expression of markers seen in other morphologic patterns Usually cytokeratin +ve
381
Biphasic/mixed pattern malignant mesothelioma
Contains both epitheliooid and sarcomatoid patterns
382
Clinic malignant mesothelioma
Chest pain, dyspnea, recurrent pleural effusions 20% with pulmonary asbestosis (fibrosis) Metastasize to the hilar lymph nodes, lung, liver and other organs 50% 1 year mortality, few survive > 2 years Can arise in other areas (peritoneum, pericardium, etc.) And if affects the GI tract, can lead to death due to intestinal obstruction or inanition